<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1165" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1165/" /><meta name="ncbi_pagename" content="Myotonic Dystrophy Type 1 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Myotonic Dystrophy Type 1 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Myotonic Dystrophy Type 1" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/10/03" /><meta name="citation_author" content="Thomas D Bird" /><meta name="citation_pmid" content="20301344" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1165/" /><meta name="citation_keywords" content="Steinert's Disease" /><meta name="citation_keywords" content="Steinert's Disease" /><meta name="citation_keywords" content="DM1" /><meta name="citation_keywords" content="Myotonin-protein kinase" /><meta name="citation_keywords" content="DMPK" /><meta name="citation_keywords" content="Myotonic Dystrophy Type 1" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Myotonic Dystrophy Type 1" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Thomas D Bird" /><meta name="DC.Date" content="2019/10/03" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1165/" /><meta name="description" content="Myotonic dystrophy type 1 (DM1) is a multisystem disorder that affects skeletal and smooth muscle as well as the eye, heart, endocrine system, and central nervous system. The clinical findings, which span a continuum from mild to severe, have been categorized into three somewhat overlapping phenotypes: mild, classic, and congenital." /><meta name="og:title" content="Myotonic Dystrophy Type 1" /><meta name="og:type" content="book" /><meta name="og:description" content="Myotonic dystrophy type 1 (DM1) is a multisystem disorder that affects skeletal and smooth muscle as well as the eye, heart, endocrine system, and central nervous system. The clinical findings, which span a continuum from mild to severe, have been categorized into three somewhat overlapping phenotypes: mild, classic, and congenital." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1165/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/myotonic-d/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1165/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A244DE04149E10000000008EB0365.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1165_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1165_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/myotonia-c/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/myotonic-d2/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1165_"><span class="title" itemprop="name">Myotonic Dystrophy Type 1</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Steinert's Disease</div><p class="contrib-group"><span itemprop="author">Thomas D Bird</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1165_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1165_ai__"><div class="contrib half_rhythm"><span itemprop="author">Thomas D Bird</span>, MD<div class="affiliation small">Seattle VA Medical Center<br />Departments of Neurology and Medicine<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.notgnihsaw.u@zornmot" class="oemail">ude.notgnihsaw.u@zornmot</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 17, 1999</span>; Last Revision: <span itemprop="dateModified">October 3, 2019</span>.</p><p><em>Estimated reading time: 35 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="myotonic-d.Summary" itemprop="description"><h2 id="_myotonic-d_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Myotonic dystrophy type 1 (DM1) is a multisystem disorder that affects skeletal and smooth muscle as well as the eye, heart, endocrine system, and central nervous system. The clinical findings, which span a continuum from mild to severe, have been categorized into three somewhat overlapping phenotypes: mild, classic, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>.</p><ul><li class="half_rhythm"><div>Mild DM1 is characterized by cataract and mild myotonia (sustained muscle contraction); life span is normal.</div></li><li class="half_rhythm"><div>Classic DM1 is characterized by muscle weakness and wasting, myotonia, cataract, and often cardiac conduction abnormalities; adults may become physically disabled and may have a shortened life span.</div></li><li class="half_rhythm"><div>Congenital DM1 is characterized by hypotonia and severe generalized weakness at birth, often with respiratory insufficiency and early death; intellectual disability is common.</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>DM1 is caused by expansion of a CTG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> in the noncoding region of <i>DMPK</i>. The diagnosis of DM1 is suspected in individuals with characteristic muscle weakness and is confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>DMPK</i>. CTG repeat length exceeding 34 repeats is abnormal. Molecular genetic testing detects pathogenic variants in nearly 100% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Use of ankle-foot orthoses, wheelchairs, or other assistive devices; special education support for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children; treatment of hypothyroidism; management of pain; consultation with a cardiologist for symptoms or ECG evidence of arrhythmia; removal of cataracts if vision is impaired; hormone replacement therapy for males with hypogonadism; surgical excision of pilomatrixoma and basal cell carcinomas.</p><p><i>Prevention of secondary complications:</i> Choice of induction agents, airway care, local anesthesia, and neuromuscular blockade to minimize complications during surgery; cardiac pacemakers or implantable cardioverter-defibrillators may prevent life-threatening arrhythmias; continue physical activity and maintain appropriate weight.</p><p><i>Surveillance:</i> Annual ECG or 24-hour Holter monitoring; annual measurement of fasting serum glucose concentration and glycosylated hemoglobin concentration; ophthalmology examination every two years; attention to nutritional status; polysomnography for sleep disturbances.</p><p><i>Agents/circumstances to avoid:</i> Cholesterol-lowering medications (i.e., statins), which can cause muscle pain and weakness; the anesthetic agent vecuronium; succinylcholine, propofol, and doxorubicin; smoking; obesity; illicit drug use; excessive alcohol intake.</p><p><i>Evaluation of relatives at risk:</i> Molecular genetic testing for early diagnosis of relatives at risk to allow treatment of cardiac manifestations, diabetes mellitus, and cataracts.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>DM1 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Offspring of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual have a 50% chance of inheriting the expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. Pathogenic alleles may expand in length during gametogenesis, resulting in the transmission of longer <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> alleles that may be associated with earlier onset and more severe disease than that observed in the parent. Prenatal testing is possible for pregnancies at increased risk when the diagnosis of DM1 has been confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> in an affected family member.</p></div></div><div id="myotonic-d.Diagnosis"><h2 id="_myotonic-d_Diagnosis_">Diagnosis</h2><div id="myotonic-d.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Myotonic dystrophy type 1 (DM1) <b>should be suspected</b> in adults with the following:</p><ul><li class="half_rhythm"><div>Muscle weakness, especially of the distal leg, hand, neck, and face</div></li><li class="half_rhythm"><div>Myotonia (sustained muscle contraction), which often manifests as the inability to quickly release a hand grip (grip myotonia) and which can be demonstrated by tapping a muscle (e.g., the thenar muscles) with a reflex hammer (percussion myotonia)</div></li><li class="half_rhythm"><div>Posterior subcapsular cataracts detectable as red and green iridescent opacities on slit lamp examination</div></li></ul><p>DM1 <b>should be suspected</b> in neonates with some combination of the following:</p><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Facial muscle weakness</div></li><li class="half_rhythm"><div>Generalized weakness</div></li><li class="half_rhythm"><div>Positional malformations including clubfoot</div></li><li class="half_rhythm"><div>Respiratory insufficiency</div></li></ul></div><div id="myotonic-d.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of DM1 <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>DMPK</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1165/table/myotonic-d.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figmyotonicdTmoleculargenetictestingu" rid-ob="figobmyotonicdTmoleculargenetictestingu">Table 1</a>).</p><p><b>Allele sizes.</b> Reference ranges for <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> sizes were established by the Second International Myotonic Dystrophy Consortium (IDMC) in 1999 [<a class="bk_pop" href="#myotonic-d.REF.international_myotonic_dystrophy_consortium.2000.1218">International Myotonic Dystrophy Consortium 2000</a>, <a class="bk_pop" href="#myotonic-d.REF.moxley.2008">Moxley &#x00026; Meola 2008</a>]. See <a class="bk_pop" href="#myotonic-d.REF.prior.2009">Prior [2009]</a> and <a class="bk_pop" href="#myotonic-d.REF.kamsteeg.2012.1203">Kamsteeg et al [2012]</a> for technical standards and guidelines for testing.</p><ul><li class="half_rhythm"><div><b>Normal alleles.</b> 5-34 CTG repeats</div></li><li class="half_rhythm"><div><b>Mutable normal (<a class="def" href="/books/n/gene/glossary/def-item/premutation/">premutation</a>) alleles.</b> 35-49 CTG repeats. Individuals with CTG expansions in the premutation range have not been reported to have symptoms, but their children are at increased risk of inheriting a larger repeat size and thus having symptoms.</div></li><li class="half_rhythm"><div><b>Full-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> alleles.</b> &#x0003e;50 CTG repeats. Full-penetrance alleles are associated with disease manifestations.</div></li></ul><p>See <a href="#myotonic-d.References">Published Guidelines / Consensus Statements</a>.</p><div id="myotonic-d.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p>Testing approaches include the following:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Targeted analysis</b> for an increased number (i.e., an expansion) of the CTG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> in <i>DMPK</i></div></li><li class="half_rhythm"><div class="half_rhythm"><b>A panel</b> that includes testing for the <i>DMPK</i> CTG repeat expansion and other disorders of interest (see <a href="#myotonic-d.Differential_Diagnosis">Differential Diagnosis</a>) may be considered to identify the genetic cause of the condition at the most reasonable cost as quickly as possible. Note: (1) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a panel that includes analysis for nucleotide repeats and other non-sequencing-based tests (e.g., <i>SMN1</i> copy number analysis, <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> testing for <a href="/books/n/gene/pws/">Prader-Willi syndrome</a>, UPD14 analysis) is recommended (see <a class="figpopup" href="/books/NBK1165/table/myotonic-d.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figmyotonicdTmoleculargenetictestingu" rid-ob="figobmyotonicdTmoleculargenetictestingu">Table 1</a>). (2) Although the CTG repeat expansion will not be detected by a <b>multigene sequencing panel</b>, this testing may be appropriate for some conditions in the differential diagnosis. (3) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (4) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (5) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="myotonic-d.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Myotonic Dystrophy Type 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1165/table/myotonic-d.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myotonic-d.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_myotonic-d.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_myotonic-d.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_myotonic-d.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_myotonic-d.T.molecular_genetic_testing_u_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DMPK</i></td><td headers="hd_h_myotonic-d.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants&#x000a0;<sup>3</sup></td><td headers="hd_h_myotonic-d.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="myotonic-d.TF.1.1"><p class="no_margin">See <a href="/books/NBK1165/#myotonic-d.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="myotonic-d.TF.1.2"><p class="no_margin">See <a href="#myotonic-d.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="myotonic-d.TF.1.3"><p class="no_margin">Testing to quantitate the number of <i>DMPK</i> CTG trinucleotide repeats is performed by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> analysis, which reliably detects expanded alleles with about 100-150 CTG repeats. Detection of larger CTG expansions requires <a class="def" href="/books/n/gene/glossary/def-item/southern-blot/">Southern blot</a> analysis.</p></div></dd></dl></div></div></div></div><div id="myotonic-d.Other_Testing"><h4>Other Testing</h4><p><b>Electromyography (EMG).</b> A needle electrode placed in the muscle of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> adult records myotonic discharges and myopathic-appearing motor units, predominantly in distal muscles. Electrical myotonic discharges are not usually seen during infancy, but fast runs of single-fiber discharges approaching the pattern of myotonic discharges are suggestive.</p><p><b>Serum CK concentration.</b> Serum CK concentration may be mildly elevated in individuals with DM1 with weakness, but is normal in asymptomatic individuals.</p><p><b>Muscle biopsy.</b> Pathologic features observed on muscle biopsy include rows of internal nuclei (having a boxcar appearance), ring fibers, sarcoplasmic masses, type I fiber predominance and atrophy, fibrosis and fatty infiltration, and a greatly increased number of intrafusal muscle fibers [<a class="bk_pop" href="#myotonic-d.REF.thornton.2014.705">Thornton 2014</a>, <a class="bk_pop" href="#myotonic-d.REF.turner.2014.599">Turner &#x00026; Hilton-Jones 2014</a>].</p><p>Note: Non-molecular testing that has been used in the past to establish the diagnosis of DM1 currently has little role in diagnosis and is primarily used if molecular testing of <i>DMPK</i> does not identify the CTG repeat expansion and other myopathies are being considered.</p></div></div></div><div id="myotonic-d.Clinical_Characteristics"><h2 id="_myotonic-d_Clinical_Characteristics_">Clinical Characteristics</h2><div id="myotonic-d.Clinical_Description"><h3>Clinical Description</h3><p>DM1 is a systemic disease potentially affecting nearly every organ system. Clinical findings in myotonic dystrophy type 1 (DM1) span a continuum from mild to severe. <a class="bk_pop" href="#myotonic-d.REF.udd.2012.891">Udd &#x00026; Krahe [2012]</a>, <a class="bk_pop" href="#myotonic-d.REF.thornton.2014.705">Thornton [2014]</a>, and <a class="bk_pop" href="#myotonic-d.REF.turner.2014.599">Turner &#x00026; Hilton-Jones [2014]</a> provide an excellent overview of all aspects of DM1. The clinical findings have been categorized into three somewhat overlapping phenotypes (mild, classic, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>) that generally correlate with CTG repeat size (<a class="figpopup" href="/books/NBK1165/table/myotonic-d.T.correlation_of_phenotype_an/?report=objectonly" target="object" rid-figpopup="figmyotonicdTcorrelationofphenotypean" rid-ob="figobmyotonicdTcorrelationofphenotypean">Table 2</a>). The CTG repeat ranges for the phenotypes in <a class="figpopup" href="/books/NBK1165/table/myotonic-d.T.correlation_of_phenotype_an/?report=objectonly" target="object" rid-figpopup="figmyotonicdTcorrelationofphenotypean" rid-ob="figobmyotonicdTcorrelationofphenotypean">Table 2</a> have considerable overlap and CTG repeat size should not be used to predict disease severity [<a class="bk_pop" href="#myotonic-d.REF.moxley.2008">Moxley &#x00026; Meola 2008</a>, <a class="bk_pop" href="#myotonic-d.REF.wenninger.2018.303">Wenninger et al 2018</a>].</p><div id="myotonic-d.T.correlation_of_phenotype_an" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Correlation of Phenotype and CTG Repeat Length in Myotonic Dystrophy Type 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1165/table/myotonic-d.T.correlation_of_phenotype_an/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myotonic-d.T.correlation_of_phenotype_an_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Signs</th><th id="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CTG Repeat Size&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Age of Onset</th><th id="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Average Age of Death</th></tr></thead><tbody><tr><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Mutable normal</b><br /><b>(<a class="def" href="/books/n/gene/glossary/def-item/premutation/">premutation</a>)</b></td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">35-49</td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr><tr><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Mild</b></td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cataracts</div></li><li class="half_rhythm"><div>Mild myotonia</div></li></ul>
</td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50-~150</td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20-70 yrs</td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">60 yrs to normal life span</td></tr><tr><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Classic</b></td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Weakness</div></li><li class="half_rhythm"><div>Myotonia</div></li><li class="half_rhythm"><div>Cataracts</div></li><li class="half_rhythm"><div>Balding</div></li><li class="half_rhythm"><div>Cardiac arrhythmia</div></li></ul>
</td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100-~1,000</td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10-30 yrs</td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">48-55 yrs</td></tr><tr><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Congenital</b></td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Infantile hypotonia</div></li><li class="half_rhythm"><div>Respiratory deficits</div></li><li class="half_rhythm"><div>Intellectual disability</div></li><li class="half_rhythm"><div>Classic signs in adults</div></li></ul>
</td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;1,000&#x000a0;<sup>3</sup></td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Birth to 10 yrs</td><td headers="hd_h_myotonic-d.T.correlation_of_phenotype_an_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">45 yrs&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">From <a class="bk_pop" href="#myotonic-d.REF.de_diesmulders.1998.1557">de Die-Smulders et al [1998]</a>, <a class="bk_pop" href="#myotonic-d.REF.mathieu.1999.1658">Mathieu et al [1999]</a>, <a class="bk_pop" href="#myotonic-d.REF.international_myotonic_dystrophy_consortium.2000.1218">International Myotonic Dystrophy Consortium [2000]</a></p></div></dd><dt></dt><dd><div><p class="no_margin">NA = not applicable</p></div></dd><dt>1. </dt><dd><div id="myotonic-d.TF.2.1"><p class="no_margin">CTG repeat sizes are known to overlap between phenotypes.</p></div></dd><dt>2. </dt><dd><div id="myotonic-d.TF.2.2"><p class="no_margin">Normal CTG repeat size is 5-34.</p></div></dd><dt>3. </dt><dd><div id="myotonic-d.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#myotonic-d.REF.redman.1993.1960">Redman et al [1993]</a> reported a few individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1 with repeats between 730 and 1,000.</p></div></dd><dt>4. </dt><dd><div id="myotonic-d.TF.2.4"><p class="no_margin">Does not include neonatal deaths</p></div></dd></dl></div></div></div><div id="myotonic-d.Mild_DM1"><h4>Mild DM1</h4><p>Individuals with mild DM1 may have only cataract, mild myotonia, or diabetes mellitus. They may have fully active lives and a normal or minimally shortened life span [<a class="bk_pop" href="#myotonic-d.REF.arsenault.2006.1248">Arsenault et al 2006</a>].</p></div><div id="myotonic-d.Classic_DM1"><h4>Classic DM1</h4><p>Within this range of CTG repeat size, only a rough correlation with severity of symptoms exists. Individuals with CTG repeat sizes in the 100-to-1,000 range usually develop classic DM1 with muscle weakness and wasting, myotonia, cataracts, and often cardiac conduction abnormalities.</p><p>While the age of onset for classic DM1 is typically in the 20s and 30s (and less commonly after age 40 years), classic DM1 may be evident in childhood, when subtle signs such as myotonia and typical facial features including ptosis, weak eyelid closure, weak smile, and thin face are observed.</p><p><b>Muscle.</b> In individuals with classic DM1, the predominant symptom is distal muscle weakness, leading to foot drop / gait disturbance and difficulty performing tasks that require fine manual dexterity. The typical facial appearance is mainly caused by weakness of the facial and levator palpebrae muscles. Myotonia may interfere with daily activities such as using tools, household equipment, or doorknobs. Handgrip myotonia and strength may improve with repeated contractions (the so-called warm-up phenomenon) [<a class="bk_pop" href="#myotonic-d.REF.logigian.2005.35">Logigian et al 2005</a>]. The warm-up phenomenon can also improve dysarthric speech [<a class="bk_pop" href="#myotonic-d.REF.de_swart.2004.1480">de Swart et al 2004</a>]. Muscle weakness is progressive but slow, and correlates with disease duration and CTG repeat expansion size [<a class="bk_pop" href="#myotonic-d.REF.bouchard.2015.285">Bouchard et al 2015</a>].</p><p>Fatigue is a common finding [<a class="bk_pop" href="#myotonic-d.REF.kalkman.2005.1406">Kalkman et al 2005</a>].</p><p>Musculoskeletal pain is fairly common, especially in the lower limbs.</p><p><b>Cardiac.</b> Cardiac conduction defects of varying degrees of severity are common. In one series, 90% of individuals had conduction defects. These defects are a significant cause of early mortality in individuals with DM1 and are sometimes associated with sudden death. A cardiac pacemaker is sometimes indicated. Less commonly, dilated cardiomyopathy may occur [<a class="bk_pop" href="#myotonic-d.REF.benhayon.2015.305">Benhayon et al 2015</a>, <a class="bk_pop" href="#myotonic-d.REF.lau.2015.600">Lau et al 2015</a>, <a class="bk_pop" href="#myotonic-d.REF.chongnguyen.2017.10">Chong-Nguyen et al 2017</a>, <a class="bk_pop" href="#myotonic-d.REF.wahbi.2017.751">Wahbi et al 2017</a>]. Atrial fibrillation in DM1 carries an increased risk of stroke [<a class="bk_pop" href="#myotonic-d.REF.yoshida.2018.914">Yoshida et al 2018</a>].</p><p><b>Pulmonary.</b> Progressive impairment of lung function can occur and may require mechanical ventilation [<a class="bk_pop" href="#myotonic-d.REF.thil.2017.816">Thil et al 2017</a>, <a class="bk_pop" href="#myotonic-d.REF.boussa_d.2018.1075">Boussa&#x000ef;d et al 2018</a>].</p><p><b>GI.</b> Smooth muscle involvement may produce dysphagia, constipation, intestinal pseudo-obstruction, or diarrhea [<a class="bk_pop" href="#myotonic-d.REF.r_nnblom.1996.654">R&#x000f6;nnblom et al 1996</a>, <a class="bk_pop" href="#myotonic-d.REF.bellini.2006.1821">Bellini et al 2006</a>, <a class="bk_pop" href="#myotonic-d.REF.glaser.2015.424">Glaser et al 2015</a>, <a class="bk_pop" href="#myotonic-d.REF.hilbert.2017.1348">Hilbert et al 2017</a>]. Oropharyngeal dysphagia and swallowing problems have been studied by <a class="bk_pop" href="#myotonic-d.REF.ercolin.2013.446">Ercolin et al [2013]</a>.</p><p>Gallstones occur as a result of increased tone of the gallbladder sphincter [<a class="bk_pop" href="#myotonic-d.REF.hilbert.2017.1348">Hilbert et al 2017</a>].</p><p>Liver function tests (e.g., transaminases) are often elevated for unclear reasons [<a class="bk_pop" href="#myotonic-d.REF.heatwole.2006.1149">Heatwole et al 2006</a>].</p><p><b>Cognition and CNS changes.</b> Minor intellectual deficits are present in some individuals, but in others intelligence may be incorrectly assumed to be reduced because of the dull facial expression. Age-related cognitive decline has been reported in some adults [<a class="bk_pop" href="#myotonic-d.REF.modoni.2008.1737">Modoni et al 2008</a>]. Overall full-scale IQ tends to be lower in individuals with both mild and classic DM1 [<a class="bk_pop" href="#myotonic-d.REF.jean.2014.186">Jean et al 2014</a>]. Working memory, executive function, and processing speed can be reduced [<a class="bk_pop" href="#myotonic-d.REF.fujino.2018.742">Fujino et al 2018</a>].</p><p>Frontal-parietal lobe deficits have been documented on formal testing [<a class="bk_pop" href="#myotonic-d.REF.sistiaga.2010.487">Sistiaga et al 2010</a>].</p><p>Avoidant, obsessive-compulsive, and passive-aggressive personality features have been reported [<a class="bk_pop" href="#myotonic-d.REF.delaporte.1998.635">Delaporte 1998</a>, <a class="bk_pop" href="#myotonic-d.REF.winblad.2005.287">Winblad et al 2005</a>]. <a class="bk_pop" href="#myotonic-d.REF.peric.2014.219">Peric et al [2014]</a> reported pathologic personality traits in 58% of 62 individuals tested, the two most common being dependent and/or paranoid personality.</p><p>In one study of 200 individuals with DM1, personality traits and psychological symptoms were usually in the normal range, but 27% were at high risk of developing a psychiatric disorder [<a class="bk_pop" href="#myotonic-d.REF.bertrand.2015.49">Bertrand et al 2015</a>].</p><p>Anxiety and depression are often seen and general quality of life can be seriously impaired [<a class="bk_pop" href="#myotonic-d.REF.antonini.2006.181">Antonini et al 2006</a>].</p><p>Hypersomnia and sleep apnea are other well-recognized manifestations that appear later [<a class="bk_pop" href="#myotonic-d.REF.rubinsztein.1998.510">Rubinsztein et al 1998</a>, <a class="bk_pop" href="#myotonic-d.REF.laberge.2009.642">Laberge et al 2009</a>]. Excessive daytime sleepiness is often caused by a central dysfunction of sleep regulation, but all types of sleep disorders have been reported [<a class="bk_pop" href="#myotonic-d.REF.dauvilliers.2012.539">Dauvilliers &#x00026; Laberge 2012</a>, <a class="bk_pop" href="#myotonic-d.REF.bonanni.2018.414">Bonanni et al 2018</a>]. Twenty of 40 individuals with DM1 had obstructive sleep apnea [<a class="bk_pop" href="#myotonic-d.REF.pincherle.2012.219">Pincherle et al 2012</a>].</p><p>Brain MRI may demonstrate mild cortical atrophy and white matter abnormalities. The white matter changes can be diffuse and extensive [<a class="bk_pop" href="#myotonic-d.REF.caso.2014.e104697">Caso et al 2014</a>, <a class="bk_pop" href="#myotonic-d.REF.okkersen.2017.960">Okkersen et al 2017</a>]. Proton magnetic resonance spectroscopy shows probable glutamatergic neuronal degeneration in frontal cortex and white matter [<a class="bk_pop" href="#myotonic-d.REF.takado.2015.247">Takado et al 2015</a>].</p><p>At autopsy, brain neurons may contain tau-associated neurofibrillary tangles [<a class="bk_pop" href="#myotonic-d.REF.cailletboudin.2014.57">Caillet-Boudin et al 2014</a>].</p><p><b>Nerve.</b> An axonal peripheral neuropathy may add to the weakness but may be uncommon [<a class="bk_pop" href="#myotonic-d.REF.bae.2008.1120">Bae et al 2008</a>]. <a class="bk_pop" href="#myotonic-d.REF.peric.2013.331">Peric et al [2013]</a> found evidence of neuropathy by nerve conduction studies in one third of 111 individuals with DM1.</p><p><b>Eye.</b> Cataracts can eventually be observed as having characteristic multicolored "Christmas tree" appearance by slit lamp examination in nearly all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. They may cause visual symptoms at any age, but usually in the 30s-40s.</p><p>Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have ophthalmoplegia.</p><p><b>Endocrine.</b> Endocrinopathies including hyperinsulinism, thyroid dysfunction, diabetes mellitus, calcium dysregulation, testicular atrophy, and possible abnormalities in growth hormone secretion can be observed, although they are rarely clinically significant. Infertility may occur in otherwise asymptomatic persons [<a class="bk_pop" href="#myotonic-d.REF.matsumura.2009.60">Matsumura et al 2009</a>]. The largest published study of these endocrine abnormalities is that of <a class="bk_pop" href="#myotonic-d.REF._rngreen.2012.912">&#x000d8;rngreen et al [2012]</a>. Secondary hyperparathyroidism with normal serum calcium and low 25-hydroxy vitamin D has been reported in up to 18% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons [<a class="bk_pop" href="#myotonic-d.REF.passeri.2013.132">Passeri et al 2013</a>].</p><p><b>Skin.</b> Pilomatrixomata and epitheliomas can occur, especially on the scalp, and can be confused with sebaceous cysts [<a class="bk_pop" href="#myotonic-d.REF.zampetti.2015.85">Zampetti et al 2015</a>]. Androgenic alopecia is also common [<a class="bk_pop" href="#myotonic-d.REF.campanati.2015.409">Campanati et al 2015</a>].</p><p><b>Cancer risk.</b> Individuals with DM1 may be at increased risk for thyroid, uterine, choroidal melanoma, and possibly colon, testicular, and prostate cancers [<a class="bk_pop" href="#myotonic-d.REF.win.2012.130">Win et al 2012</a>, <a class="bk_pop" href="#myotonic-d.REF.abbott.2016.783">Abbott et al 2016</a>, <a class="bk_pop" href="#myotonic-d.REF.emparanza.2018.517">Emparanza et al 2018</a>]. There was no increased risk of cancer in relatives who did not have DM [<a class="bk_pop" href="#myotonic-d.REF.lund.2014.1192">Lund et al 2014</a>]. Risk of skin cancer is increased, especially basal cell [<a class="bk_pop" href="#myotonic-d.REF.marcoval.2016.700">Marcoval et al 2016</a>, <a class="bk_pop" href="#myotonic-d.REF.wang.2018.1174">Wang et al 2018</a>].</p><p><b>Disease course.</b> Rarely, after several decades of disease, DM1 progresses to the point of wheelchair confinement. Weakness/myotonia of the diaphragm and a susceptibility to aspiration increase the risk for respiratory compromise, usually in individuals with advanced disease [<a class="bk_pop" href="#myotonic-d.REF.roses.1997">Roses 1997</a>]. Slow progression of weakness has been documented in a nine-year study [<a class="bk_pop" href="#myotonic-d.REF.raymond.2017.673">Raymond et al 2017</a>]. Falls resulting in bone fractures are common [<a class="bk_pop" href="#myotonic-d.REF.jim_nezmoreno.2018.229">Jim&#x000e9;nez-Moreno et al 2018</a>].</p><p>Several studies have evaluated life span and mortality in DM1 (<a class="figpopup" href="/books/NBK1165/table/myotonic-d.T.correlation_of_phenotype_an/?report=objectonly" target="object" rid-figpopup="figmyotonicdTcorrelationofphenotypean" rid-ob="figobmyotonicdTcorrelationofphenotypean">Table 2</a>) [<a class="bk_pop" href="#myotonic-d.REF.de_diesmulders.1998.1557">de Die-Smulders et al 1998</a>, <a class="bk_pop" href="#myotonic-d.REF.mathieu.1999.1658">Mathieu et al 1999</a>]. The most common causes of death are pneumonia / respiratory failure, cardiovascular disease, sudden death / arrhythmia, and neoplasms [<a class="bk_pop" href="#myotonic-d.REF.benhayon.2015.305">Benhayon et al 2015</a>, <a class="bk_pop" href="#myotonic-d.REF.johnson.2015.659">Johnson et al 2015</a>]. In the study of <a class="bk_pop" href="#myotonic-d.REF.de_diesmulders.1998.1557">de Die-Smulders et al [1998]</a> 50% of individuals with DM1 were either partially or totally wheelchair bound shortly before death. The cumulative probability of 15-year survival in Belgrade was 50% [<a class="bk_pop" href="#myotonic-d.REF.mladenovic.2006.451">Mladenovic et al 2006</a>]. Both early age of onset and decreased survival correlate with larger CTG repeat expansions [<a class="bk_pop" href="#myotonic-d.REF.groh.2011.648">Groh et al 2011</a>]. Survival correlates with age, diabetes, need for walking support, cardiac arrhythmia, blood pressure, and vital capacity [<a class="bk_pop" href="#myotonic-d.REF.wahbi.2018.573">Wahbi et al 2018</a>].</p></div><div id="myotonic-d.Congenital_DM1"><h4>Congenital DM1</h4><p>A transmission ratio distortion at conception favors transmission of larger CTG repeats than those present in the parent [<a class="bk_pop" href="#myotonic-d.REF.dean.2006.299">Dean et al 2006</a>]. The mother is almost always the parent who transmits the larger repeat, although transmission by the father has been reported [<a class="bk_pop" href="#myotonic-d.REF.zeesman.2002.222">Zeesman et al 2002</a>]. Presence of a large repeat may lead to earlier onset and more severe disease, known as <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1 [<a class="bk_pop" href="#myotonic-d.REF.rakocevi_stojanovi_.2005.236">Rakocevi&#x00107;-Stojanovi&#x00107; et al 2005</a>].</p><p><b>Prenatal.</b> Congenital DM1 often presents before birth as polyhydramnios and reduced fetal movement.</p><p><b>Neonatal.</b> After delivery, the main features are severe generalized weakness, hypotonia, and respiratory compromise. Typically, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants have an inverted V-shaped (also termed "tented" or "fish-shaped") upper lip, which is characteristic of significant facial diplegia (weakness). Mortality from respiratory failure is common.</p><p><b>Infancy and childhood.</b> Surviving infants experience gradual improvement in motor function. Affected children are usually able to walk; however, a progressive myopathy occurs eventually, as in the classic form [<a class="bk_pop" href="#myotonic-d.REF.harper.2001">Harper 2001</a>, <a class="bk_pop" href="#myotonic-d.REF.johnson.2016.160">Johnson et al 2016</a>]. These individuals may develop any of the typical features of DM1 including weakness, myotonia, cataracts, and cardiac problems. Strength improves during early childhood, then begins to decrease during the second decade [<a class="bk_pop" href="#myotonic-d.REF.kroksmark.2017.826">Kroksmark et al 2017</a>].</p><ul><li class="half_rhythm"><div><b>Intellectual disability</b> is present in 50%-60% of individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1. The cause of the intellectual disability is unclear, but cerebral atrophy and ventricular dilation are often evident at birth. Intellectual disability may result from a combination of early respiratory failure and a direct effect of the <i>DMPK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on the brain [<a class="bk_pop" href="#myotonic-d.REF.ekstr_m.2009.982">Ekstr&#x000f6;m et al 2009</a>]. Autism spectrum disorder may be observed [<a class="bk_pop" href="#myotonic-d.REF.ekstr_m.2008.918">Ekstr&#x000f6;m et al 2008</a>]. <a class="bk_pop" href="#myotonic-d.REF.douniol.2012.905">Douniol et al [2012]</a> have reported common mood/anxiety disorders, impaired attention, and abnormal visual-spatial abilities. Delusions and psychotic features can occur [<a class="bk_pop" href="#myotonic-d.REF.jacobs.2017.359">Jacobs et al 2017</a>].</div></li><li class="half_rhythm"><div><b>Vision.</b> Children with DM1 may have low visual acuity, hyperopia, or astigmatism [<a class="bk_pop" href="#myotonic-d.REF.ekstr_m.2010.976">Ekstr&#x000f6;m et al 2010</a>].</div></li><li class="half_rhythm"><div><b>Sleep.</b> Excessive daytime sleepiness can affect quality of life [<a class="bk_pop" href="#myotonic-d.REF.ho.2017.92">Ho et al 2017</a>].</div></li></ul></div></div><div id="myotonic-d.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>In general, longer CTG repeat expansions correlate with an earlier age of onset and more severe disease [<a class="bk_pop" href="#myotonic-d.REF.logigian.2004.1081">Logigian et al 2004</a>] (<a class="figpopup" href="/books/NBK1165/table/myotonic-d.T.correlation_of_phenotype_an/?report=objectonly" target="object" rid-figpopup="figmyotonicdTcorrelationofphenotypean" rid-ob="figobmyotonicdTcorrelationofphenotypean">Table 2</a>). Small but abnormal repeats (50-99) are often associated with a mild or asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#myotonic-d.REF.arsenault.2006.1248">Arsenault et al 2006</a>].</p><p>The <i>DMPK</i> CTG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> length is mitotically unstable in individuals with DM1. Such instability very often leads to <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the size of the CTG expansion; therefore, correlation between CTG repeat size observed in one tissue and disease severity may not be possible [<a class="bk_pop" href="#myotonic-d.REF.moxley.2008">Moxley &#x00026; Meola 2008</a>]. Studies have attempted to estimate the progenitor <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> CTG repeat length (ePAL) and somatic mutational dynamics [<a class="bk_pop" href="#myotonic-d.REF.cumming.2019.e995">Cumming et al 2019</a>]. ePAL refers to the subject&#x02019;s CTG repeat size at the time of birth, which often increases over the next decades. It is also known that 3%-8% of DM1 expansions contain variant repeats such as CCG and CGG. Such repeats may influence disease severity and delay age at onset.</p><p>A person who was a compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> for expanded alleles with 1,260 and 60 CTG repeats was reported to have cerebral abnormalities [<a class="bk_pop" href="#myotonic-d.REF.cerghet.2008.930">Cerghet et al 2008</a>].</p></div><div id="myotonic-d.Penetrance"><h3>Penetrance</h3><p>Penetrance is high (nearly 100% by age 50 years) when all manifestations of the disease, even those that are subtle, are sought. However, mild cases (e.g., persons with only cataracts) may be missed [<a class="bk_pop" href="#myotonic-d.REF.moxley.2008">Moxley &#x00026; Meola 2008</a>].</p></div><div id="myotonic-d.Anticipation"><h3>Anticipation</h3><p>Because <i>DMPK</i> alleles of CTG length greater than 34 repeats are unstable and may expand in length during meiosis, at-risk offspring may inherit repeat lengths considerably longer than those present in the transmitting parent. This phenomenon results in <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a>, the occurrence of increasing disease severity and decreasing age of onset in successive generations.</p><p>Most often a child with early-onset, severe DM1 (i.e., <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1) has inherited the expanded <i>DMPK</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> from the mother [<a class="bk_pop" href="#myotonic-d.REF.martorell.2007.68">Martorell et al 2007</a>]. Although <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> typically occurs in maternal transmission of the disease, anticipation with paternal transmission is possible [<a class="bk_pop" href="#myotonic-d.REF.moxley.2008">Moxley &#x00026; Meola 2008</a>].</p><p>In a study of children of parents with small expansions (50-100 CTG repeats), those with expanded alleles transmitted paternally had a larger increase in CTG repeats (median: 425 repeats; range: 70-2,000) than did those with maternally transmitted expanded alleles (median: 200 repeats; range: 57-1,400) [<a class="bk_pop" href="#myotonic-d.REF.pratte.2015.708">Pratte et al 2015</a>].</p></div><div id="myotonic-d.Prevalence"><h3>Prevalence</h3><p>Estimates of the prevalence of DM1 range from 1:100,000 in some areas of Japan to 1:10,000 in Iceland, with an overall estimated worldwide prevalence of 1:20,000 [<a class="bk_pop" href="#myotonic-d.REF.theadom.2014.259">Theadom et al 2014</a>].</p><p>Founder effects may increase the prevalence in specific regions, such as Quebec [<a class="bk_pop" href="#myotonic-d.REF.yotova.2005.177">Yotova et al 2005</a>, <a class="bk_pop" href="#myotonic-d.REF.pratte.2015.708">Pratte et al 2015</a>].</p></div></div><div id="myotonic-d.Genetically_Related_Allelic_D"><h2 id="_myotonic-d_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>DMPK</i>.</p></div><div id="myotonic-d.Differential_Diagnosis"><h2 id="_myotonic-d_Differential_Diagnosis_">Differential Diagnosis</h2><p>Hypotonia in infancy is seen in many disorders, including <a href="/books/n/gene/pws/">Prader-Willi syndrome</a>, multiminicore disease (OMIM <a href="https://omim.org/entry/606210" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606210</a>, <a href="https://omim.org/entry/180901" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">180901</a>), nemaline myopathy (OMIM <a href="https://omim.org/phenotypicSeries/PS161800" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS161800</a>), <a href="/books/n/gene/mtm/">X-linked centronuclear myopathy</a>, other centronuclear myopathies (OMIM <a href="https://www.omim.org/phenotypicSeries/PS160150" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS160150</a>), and maternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 14.</p><p><a href="/books/n/gene/myotonic-d2/"><b>Myotonic dystrophy type 2</b></a> (DM2) is characterized by myotonia (90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) and muscle dysfunction (weakness, pain, and stiffness) (82%), and less commonly by cardiac conduction defects, iridescent posterior subcapsular cataracts, insulin-insensitive type 2 diabetes mellitus, and testicular failure. Although myotonia has been reported during the first decade, onset is typically in the third decade, most commonly with fluctuating or episodic muscle pain that can be debilitating and weakness of the neck flexors and finger flexors. Subsequently, weakness occurs in the elbow extensors and the hip flexors and extensors. Facial weakness and weakness of the ankle dorsiflexors are less common. Myotonia rarely causes severe symptoms. A detailed comparison between DM1 and DM2 has been reported [<a class="bk_pop" href="#myotonic-d.REF.wenninger.2018.303">Wenninger et al 2018</a>]. DM2 is caused by pathogenic variants in <i>CNBP</i>. <i>CNBP</i> <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 1 contains a complex repeat motif, (TG)n(TCTG)n(CCTG)n. Expansion of the CCTG repeat causes DM2. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p>DM2 is the only other known genetic form of multisystem myotonic dystrophy identified to date (although others likely exist). The distinction between DM1, DM2, and other inherited myopathies is made by determining the number of CTG repeats in <i>DMPK</i>. If the <i>DMPK</i> CTG repeat length is in the normal range and if DM2 has been excluded by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>CNBP</i>, further testing with EMG, serum CK concentration, and/or muscle biopsy is often warranted to evaluate for other causes of muscle disease.</p><p><b>Note:</b> The International Myotonic Dystrophy Consortium (IDMC) has agreed that any newly identified multisystem myotonic dystrophies will be sequentially named as forms of myotonic dystrophy. One family posited to have DM3 [<a class="bk_pop" href="#myotonic-d.REF.le_ber.2004.1979">Le Ber et al 2004</a>] was subsequently shown to have an unusual presentation of <a href="/books/n/gene/ibmpfd/">inclusion body myopathy with Paget disease and frontotemporal dementia</a> [<a class="bk_pop" href="#myotonic-d.REF.udd.2006.403">Udd et al 2006</a>] caused by pathogenic variants in <i>VCP</i>.</p><p><b>Hereditary distal myopathies.</b> The differential diagnosis for hereditary distal myopathies includes <a href="/books/n/gene/ibm/"><i>GNE</i>-related myopathy</a> (hereditary inclusion body myopathy 2), myofibrillar myopathy (OMIM <a href="https://omim.org/phenotypicSeries/PS601419" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS601419</a>), distal muscular dystrophy (e.g., <a href="/books/n/gene/miyoshi/">dysferlinopathy</a>, Welander [OMIM <a href="https://omim.org/entry/604454" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">604454</a>]), and the limb-girdle muscular dystrophies.</p><p><b>Hereditary myotonia.</b> Other hereditary disorders associated with myotonia are: <a href="/books/n/gene/myotonia-c/">myotonia congenita</a> (also called Thomsen disease or Becker disease), caused by pathogenic variants in <i>CLCN1</i>; paramyotonia congenita (OMIM <a href="http://omim.org/entry/168300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">168300</a>) and its variants, caused by pathogenic variants in <i>SCN4A</i>; and <a href="/books/n/gene/hyper-pp/">hyperkalemic periodic paralysis</a>, caused by pathogenic variants in <i>SCN4A</i>.</p><p>Occasionally, DM1 has been misdiagnosed as motor neuron disease (see <a href="/books/n/gene/sma/">Spinal Muscular Atrophy</a> and <a href="/books/n/gene/kennedy/">Spinal and Bulbar Muscular Atrophy</a>), cerebral palsy, nonspecific intellectual disability, or, because of "masked face" and slow movements, <a href="/books/n/gene/parkinson-overview/">parkinsonism</a>.</p></div><div id="myotonic-d.Management"><h2 id="_myotonic-d_Management_">Management</h2><div id="myotonic-d.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs <b>in adults with classic myotonic dystrophy type 1 (DM1)</b>, the evaluations summarized in <a class="figpopup" href="/books/NBK1165/table/myotonic-d.T.recommended_evaluations_fol/?report=objectonly" target="object" rid-figpopup="figmyotonicdTrecommendedevaluationsfol" rid-ob="figobmyotonicdTrecommendedevaluationsfol">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended. Consensus-based care recommendations have been published both for adults [<a class="bk_pop" href="#myotonic-d.REF.ashizawa.2018.507">Ashizawa et al 2018</a>] and for persons with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>- and childhood-onset DM1 [<a class="bk_pop" href="#myotonic-d.REF.johnson.2019.1">Johnson et al 2019</a>] and are available at <a href="https://www.myotonic.org/toolkits-publications" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.myotonic.org</a>.</p><div id="myotonic-d.T.recommended_evaluations_fol" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Adults with Myotonic Dystrophy Type 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1165/table/myotonic-d.T.recommended_evaluations_fol/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myotonic-d.T.recommended_evaluations_fol_lrgtbl__"><table><thead><tr><th id="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Baseline neurologic evaluation for strength, balance, sensation</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Excessive daytime sleepiness is common.</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To include assessment of strength &#x00026; cognitive function</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">By an ophthalmologist familiar w/iridescent posterior subcapsular cataract characteristic of DM1</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ECG &#x00026; holter monitoring</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate syncope, chest pains, palpitations, &#x00026; other symptoms of potential cardiac origin</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Echocardiogram</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider cardiology referral.</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Pulmonary function tests</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pneumonia &#x00026; flu vaccinations</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Referral to pulmonologist if symptomatic</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrine</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of thyroid function</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Liver enzyme elevation is common.</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Fasting blood glucose &#x00026; HbA1C determination</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>GI</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical assessment for poor swallowing, pseudo-obstruction, diarrhea, gallbladder dysfunction</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider internal medicine &#x00026;/or gastroenterology consultation.</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Surgery</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for history of adverse reactions to drugs &#x00026; anesthesia</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://www.myotonic.org/sites/default/files/MDF_LongForm_AnesGuidelines_01C.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Consensus guidelines</a></td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pregnancy</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Obstetric consultation</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Miscarriage &#x00026; preterm delivery is common in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women; see <a href="#myotonic-d.Pregnancy_Management">Pregnancy Management</a>.</td></tr></tbody></table></div></div><p>To establish the extent of disease and needs <b>in children diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1</b>, the evaluations summarized in <a class="figpopup" href="/books/NBK1165/table/myotonic-d.T.recommended_evaluations_fol_1/?report=objectonly" target="object" rid-figpopup="figmyotonicdTrecommendedevaluationsfol1" rid-ob="figobmyotonicdTrecommendedevaluationsfol1">Table 4</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="myotonic-d.T.recommended_evaluations_fol_1" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Children with Myotonic Dystrophy Type 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1165/table/myotonic-d.T.recommended_evaluations_fol_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myotonic-d.T.recommended_evaluations_fol_1_lrgtbl__"><table><thead><tr><th id="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Baseline neurologic evaluation</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl assessment of motor, cognitive, &#x00026; psychosocial function</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">By ophthalmologist familiar w/iridescent posterior subcapsular cataract characteristic of DM1</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ECG</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate syncope, palpitations, &#x00026; other symptoms of potential cardiac origin</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Cardiology consultation</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pulmonary function tests</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pneumonia risk</td></tr><tr><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrine</b></td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fasting blood glucose or HbA1c</td><td headers="hd_h_myotonic-d.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="myotonic-d.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management guidelines have been developed [<a class="bk_pop" href="#myotonic-d.REF.turner.2014.599">Turner &#x00026; Hilton-Jones 2014</a>, <a class="bk_pop" href="#myotonic-d.REF.ashizawa.2018.507">Ashizawa et al 2018</a>, <a class="bk_pop" href="#myotonic-d.REF.johnson.2019.1">Johnson et al 2019</a>].</p><p>No specific treatment exists for the progressive weakness in individuals with DM1.</p><p>A physiatrist, occupational therapist, or physical therapist can help evaluate <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals regarding the need for ankle-foot orthoses, wheelchairs, or other assistive devices as the disease progresses. Orthopedic surgery may benefit children with musculoskeletal deformities [<a class="bk_pop" href="#myotonic-d.REF.canavese.2009.208">Canavese &#x00026; Sussman 2009</a>].</p><p>Special education support is indicated for children with DM1.</p><p>Increased weakness in DM1 has been associated with both hypothyroidism and certain cholesterol-lowering medications (i.e., statins); thus, some strength may return if these causative factors are eliminated.</p><p>Myotonia in DM1 is typically mild to moderate and rarely requires treatment [<a class="bk_pop" href="#myotonic-d.REF.ricker.1999.170">Ricker et al 1999</a>]. Anecdotally, some individuals have responded to mexiletine or carbamazepine. <a class="bk_pop" href="#myotonic-d.REF.logigian.2010.1441">Logigian et al [2010]</a> found mexiletine 150-200 mg 3x/day effective and safe for treating myotonia.</p><p>Pain management can be an important part of DM1 treatment. Different medications and combinations of medications work for some individuals, although none has been routinely effective; medications that have been used include mexiletine, gabapentin, nonsteroidal anti-inflammatory drugs, low-dose thyroid replacement, low-dose steroids, and tricyclic antidepressants. When used as part of a comprehensive pain management program, low-dose analgesics may provide relief.</p><p>Consultation with a cardiologist is appropriate for individuals with cardiac symptoms or ECG evidence of arrhythmia because fatal arrhythmias can occur prior to other symptoms in individuals with DM1. More advanced, invasive electrophysiologic testing of the heart may be required [<a class="bk_pop" href="#myotonic-d.REF.sovari.2007.191">Sovari et al 2007</a>, <a class="bk_pop" href="#myotonic-d.REF.sochala.2017.175">Sochala et al 2017</a>, <a class="bk_pop" href="#myotonic-d.REF.russo.2018.327">Russo et al 2018</a>].</p><p>Cataracts can be removed if they impair vision. Recurrence after surgery has been reported [<a class="bk_pop" href="#myotonic-d.REF.garrott.2004.653">Garrott et al 2004</a>].</p><p>Males with low serum concentration of testosterone require hormone replacement therapy if they are symptomatic.</p><p>In most cases, surgical excision of pilomatrixoma including clear margins and its overlying skin is the preferred treatment [<a class="bk_pop" href="#myotonic-d.REF.cigliano.2005.673">Cigliano et al 2005</a>]. Basal cell cancers require removal.</p><p>An extensive review found no evidence for successful treatment of hypersomnia with routine psychostimulants [<a class="bk_pop" href="#myotonic-d.REF.annane.2006.cd003218">Annane et al 2006</a>], although others have reported benefit [<a class="bk_pop" href="#myotonic-d.REF.talbot.2003.357">Talbot et al 2003</a>, <a class="bk_pop" href="#myotonic-d.REF.wintzen.2007.26">Wintzen et al 2007</a>].</p></div><div id="myotonic-d.Prevention_of_Secondary_Compl"><h3>Prevention of Secondary Complications</h3><p><a class="bk_pop" href="#myotonic-d.REF.veyckemans.2013.794">Veyckemans &#x00026; Scholtes [2013]</a> have reviewed the anesthetic management of individuals with DM1. Choice of induction agents, airway care, local anesthesia, and neuromuscular blockade were found to minimize complications during surgery in individuals with DM1. Avoid using succinylcholine. Propofol-induced pain can induce myotonia. Sevoflurane has been used uneventfully.</p><p>Cardiac pacemakers or implantable cardioverter-defibrillators may prevent life-threatening arrhythmias [<a class="bk_pop" href="#myotonic-d.REF.wahbi.2012.1292">Wahbi et al 2012</a>, <a class="bk_pop" href="#myotonic-d.REF.facendalorenzo.2013.193">Facenda-Lorenzo et al 2013</a>].</p><p><a class="bk_pop" href="#myotonic-d.REF.gagnon.2013.42">Gagnon et al [2013]</a> presented evidence that obesity, tobacco smoking, physical inactivity, and alcohol / illicit drug consumption are lifestyle risk factors associated with more severe DM1 phenotypes.</p><p>Mechanical ventilation for pulmonary insufficiency may be needed [<a class="bk_pop" href="#myotonic-d.REF.boussa_d.2018.1075">Boussa&#x000ef;d et al 2018</a>].</p><p>Gallbladder removal is sometimes required [<a class="bk_pop" href="#myotonic-d.REF.hilbert.2017.1348">Hilbert et al 2017</a>].</p><p>Careful attention to anesthetic management during surgery is required [<a class="bk_pop" href="#myotonic-d.REF.veyckemans.2013.794">Veyckemans &#x00026; Scholtes 2013</a>, <a class="bk_pop" href="#myotonic-d.REF.gorelik.2018.243">Gorelik &#x00026; Flores 2018</a>].</p></div><div id="myotonic-d.Surveillance"><h3>Surveillance</h3><p><a class="bk_pop" href="#myotonic-d.REF.turner.2014.599">Turner &#x00026; Hilton-Jones [2014]</a> provide guidelines for surveillance.</p><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Annual ECG to detect asymptomatic cardiac conduction defects. Some centers perform annual 24-hour Holter monitoring of individuals with DM1 who do not have cardiac symptoms [<a class="bk_pop" href="#myotonic-d.REF.s_.2007.745">S&#x000e1; et al 2007</a>, <a class="bk_pop" href="#myotonic-d.REF.sovari.2007.191">Sovari et al 2007</a>, <a class="bk_pop" href="#myotonic-d.REF.cudia.2009.790">Cudia et al 2009</a>]. Tissue Doppler monitoring has also been proposed [<a class="bk_pop" href="#myotonic-d.REF.parisi.2007.227">Parisi et al 2007</a>, <a class="bk_pop" href="#myotonic-d.REF.wahbi.2012.1292">Wahbi et al 2012</a>].</div></li><li class="half_rhythm"><div>Annual measurement of fasting serum glucose concentration and glycosylated hemoglobin concentration, with treatment for diabetes mellitus if indicated [<a class="bk_pop" href="#myotonic-d.REF.matsumura.2009.60">Matsumura et al 2009</a>]</div></li><li class="half_rhythm"><div>Ophthalmologic examination every two years to evaluate for cataract formation</div></li><li class="half_rhythm"><div>Attention to nutritional status including mastication and trouble eating [<a class="bk_pop" href="#myotonic-d.REF.motlagh.2005.713">Motlagh et al 2005</a>, <a class="bk_pop" href="#myotonic-d.REF.engvall.2009.412">Engvall et al 2009</a>, <a class="bk_pop" href="#myotonic-d.REF.umemoto.2009.210">Umemoto et al 2009</a>]</div></li><li class="half_rhythm"><div>Polysomnographic follow up of sleep complaints [<a class="bk_pop" href="#myotonic-d.REF.kumar.2007.15">Kumar et al 2007</a>]</div></li></ul></div><div id="myotonic-d.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Statins used to lower cholesterol may sometimes cause muscle pain and weakness.</p><p><a class="bk_pop" href="#myotonic-d.REF.mathieu.1997.1646">Mathieu et al [1997]</a> noted that "[n]umerous cases of perioperative complications in patients with DM have been reported. Hazards have been associated with the use of thiopentone, suxamethonium, neostigmine, and halothane. Most complications were pulmonary. The likelihood of perioperative pulmonary complications (PPC) was not related to any specific anesthetic drug. Because of the increased risk of PPC, careful monitoring during the early postoperative period, protection of the upper airways, chest physiotherapy, and incentive spirometry are mandatory in all symptomatic patients with DM, particularly those with a severe muscular disability or those who have undergone an upper abdominal surgery."</p><p><a class="bk_pop" href="#myotonic-d.REF.veyckemans.2013.794">Veyckemans &#x00026; Scholtes [2013]</a> and <a class="bk_pop" href="#myotonic-d.REF.gorelik.2018.243">Gorelik &#x00026; Flores [2018]</a> have reviewed appropriate anesthetic care for individuals with DM1 and DM2.</p><p>Malignant hyperthermia during anesthesia including the use of vecuronium [<a class="bk_pop" href="#myotonic-d.REF.nishi.2004.1216">Nishi et al 2004</a>] has been reported in DM1 but is very uncommon [<a class="bk_pop" href="#myotonic-d.REF.kirzinger.2010.842">Kirzinger et al 2010</a>]. (See <a href="/books/n/gene/mhs/">Malignant Hyperthermia Susceptibility</a>.)</p><p>Aggressive doxorubicin-based chemotherapy for lymphoma in a person with DM1 produced sudden atrial fibrillations [<a class="bk_pop" href="#myotonic-d.REF.montella.2005.192">Montella et al 2005</a>].</p><p><a class="bk_pop" href="#myotonic-d.REF.gagnon.2013.42">Gagnon et al [2013]</a> presented evidence that obesity, tobacco smoking, physical inactivity, and alcohol / illicit drug consumption are lifestyle risk factors associated with more severe DM1 phenotypes.</p></div><div id="myotonic-d.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic at-risk adult relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual to allow for early diagnosis and treatment of cardiac manifestations, diabetes mellitus, and cataracts.</p><p>See <a href="#myotonic-d.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="myotonic-d.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Women with DM1 are at risk for complications during pregnancy including increased spontaneous abortion rate, premature labor, prolonged labor, retained placenta, placenta previa, and postpartum hemorrhage [<a class="bk_pop" href="#myotonic-d.REF.zaki.2007.284">Zaki et al 2007</a>, <a class="bk_pop" href="#myotonic-d.REF.argov.2009.675">Argov &#x00026; de Visser 2009</a>]. Special surveillance during pregnancy of women with DM1 includes ultrasound examination; evaluation for placenta previa; and <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> of possible polyhydramnios, prolonged labor, and/or need for delivery by cesarean section [<a class="bk_pop" href="#myotonic-d.REF.argov.2009.675">Argov &#x00026; de Visser 2009</a>].</p><p>Complications related to the presence of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1 in the fetus include reduced fetal movement and polyhydramnios. <a class="bk_pop" href="#myotonic-d.REF.awater.2012.153">Awater et al [2012]</a> found increased rates of cesarean birth and preterm delivery among women with DM1.</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="myotonic-d.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="myotonic-d.Other"><h3>Other</h3><p>Moderate-intensity strength training does no harm, but it is unclear whether it offers measurable benefits [<a class="bk_pop" href="#myotonic-d.REF.van_der_kooi.2005.cd003907">van der Kooi et al 2005</a>]. A controlled study of an exercise program for DM1 showed neither beneficial nor detrimental effects [<a class="bk_pop" href="#myotonic-d.REF.kierkegaard.2011.695">Kierkegaard et al 2011</a>].</p></div></div><div id="myotonic-d.Genetic_Counseling"><h2 id="_myotonic-d_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="myotonic-d.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Myotonic dystrophy type 1 (DM1) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="myotonic-d.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Virtually all individuals with DM1 have inherited their expanded CTG <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> from a parent who also has an allele in the abnormal range (&#x0003e;34 CTG repeats); however, the parent with the expanded allele may or may not appear to be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. The parent may appear to be unaffected because of failure to recognize symptoms of mild DM1 or the parent may have no symptoms and have an abnormal, but small, CTG repeat expansion.</div></li><li class="half_rhythm"><div>New expansions of a normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> (&#x02264;34 CTG repeats) into the abnormal range are rare.</div></li><li class="half_rhythm"><div>If both parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are asymptomatic, it is appropriate to offer <i>DMPK</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to both for the purpose of <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> of other family members. In this instance, <a href="#myotonic-d.Related_Genetic_Counseling_Is">genetic counseling issues</a> relevant to <b>presymptomatic testing</b> should be addressed.</div></li><li class="half_rhythm"><div>If a CTG expansion in the abnormal range (&#x0003e;34 repeats) cannot be detected in the leukocyte DNA of either parent, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could be explored.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs of a proband depends on the genetic status of the parents:</p><ul><li class="half_rhythm"><div>If one parent has an expanded <i>DMPK</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, the risk to each sib is 50%.</div></li><li class="half_rhythm"><div>An expanded <i>DMPK</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> may expand further in length during gametogenesis, resulting in transmission of an allele with a larger CTG repeat that may be associated with earlier onset and more severe disease than that in the parent (see Clinical Characteristics, <a href="#myotonic-d.Anticipation">Anticipation</a>; <a href="#myotonic-d.Related_Genetic_Counseling_Is">Related Genetic Counseling Issues</a>, <b>Empiric risks for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1</b>).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with an expanded <i>DMPK</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> (&#x0003e;34 CTG repeats) has a 50% chance of inheriting the expanded <i>DMPK</i> allele.</div></li><li class="half_rhythm"><div>An expanded <i>DMPK</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> may expand further in length during gametogenesis, resulting in transmission of an allele with a larger CTG repeat that may be associated with earlier onset and more severe disease than that in the parent (see Clinical Characteristics, <a href="#myotonic-d.Anticipation">Anticipation</a>; <a href="#myotonic-d.Related_Genetic_Counseling_Is">Related Genetic Counseling Issues</a>, <b>Empiric risks for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1</b>).</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parent: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a CTG expansion in the abnormal range (&#x0003e;34 repeats), his or her family members are at risk.</p></div><div id="myotonic-d.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#myotonic-d.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>Empiric risks for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1.</b> Data concerning the likelihood that a mother with a particular CTG repeat size will have a child with a particular CTG repeat size or <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may be useful in <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> counseling. The available data have wide confidence limits, making specific risk estimates difficult.</p><ul><li class="half_rhythm"><div><a class="bk_pop" href="#myotonic-d.REF.redman.1993.1960">Redman et al [1993]</a> found that for women with a CTG repeat length of 100 or higher, the risk to a child who has inherited the abnormal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> of having an expansion of 730 or more CTG repeats (and thus <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1) is 62%. <a class="bk_pop" href="#myotonic-d.REF.martorell.2007.68">Martorell et al [2007]</a> found a similar frequency of 63% of fetuses with more than 1,000 repeats in 31 of 49 maternal transmissions of the expanded allele (mothers' abnormal allele size ranging from 65 to 1,333 CTG repeats).</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#myotonic-d.REF.cobo.1995.105">Cobo et al [1995]</a> determined that for women with a CTG repeat size smaller than 300, the risk to a child who has inherited the abnormal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> of having <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1 is 10%, and for women with a CTG repeat size greater than 300, the risk to a child who has inherited the abnormal allele of having congenital DM1 is 59%. <a class="bk_pop" href="#myotonic-d.REF.martorell.2007.68">Martorell et al [2007]</a> found a similar correlation, but there was no statistical analysis.</div></li></ul><p><b>Diagnosis of mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals during family evaluation.</b> Individuals with mild DM1 are often unaware of having DM1 and may only be diagnosed in the course of evaluation of a more severely affected family member. This often occurs when an asymptomatic mother having a CTG repeat size under 100 gives birth to an infant with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1 with a CTG repeat length in the thousands.</p><p><b>Testing of at-risk asymptomatic adult relatives</b> of individuals with DM1 is possible after <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has identified the expanded <i>DMPK</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member. Such testing should be performed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> and is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing.</p><p><b>Predictive testing in minors (i.e., testing of asymptomatic at-risk individuals younger than age 18 years).</b> For asymptomatic minors at risk for adult-onset conditions for which early treatment would have no beneficial effect on disease morbidity and mortality, predictive genetic testing is considered inappropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p><p>For more information, see the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</p><p>Testing is appropriate to consider in symptomatic individuals in a family with an established diagnosis of DM1 regardless of age.</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="myotonic-d.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>A priori high risk.</b> Once an expanded <i>DMPK</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for pregnancies at 50% risk for DM1 and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible. No effect of <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> size on reproductive outcome in preimplantation genetic diagnosis was observed in 78 couples in which 54 females and 24 males had DM1 [<a class="bk_pop" href="#myotonic-d.REF.verpoest.2010.327">Verpoest et al 2010</a>]. In these individuals the CTG repeat size ranged from 50 to 1,330 with a mean of 410. The cumulative delivery rate was 46% in 205 cycles [<a class="bk_pop" href="#myotonic-d.REF.verpoest.2008.1654">Verpoest et al 2008</a>]. In 59 cycles in 35 couples <a class="bk_pop" href="#myotonic-d.REF.fern_ndez.2017.9165363">Fern&#x000e1;ndez et al [2017]</a> found a live birth per cycle rate of 18.6%. Less favorable rates were found in affected women compared to affected men.</p><p>Note: (1) Abnormal test results do not predict the age of onset or severity of the disease because of the overlap of CTG repeat length associated with the three phenotypes and the possibility of <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the size of the CTG expansion. However, CTG repeat lengths of 730-1,000 or greater are more likely to be associated with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1 [<a class="bk_pop" href="#myotonic-d.REF.redman.1993.1960">Redman et al 1993</a>, <a class="bk_pop" href="#myotonic-d.REF.martorell.2007.68">Martorell et al 2007</a>]. (2) Ultrasound examination in the second and third trimesters may reveal decreased fetal movement and polyhydramnios, possible indicators of congenital DM1.</p><p><b>A priori low risk.</b> For fetuses not known to be at increased risk for DM1, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for an expanded <i>DMPK</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> may be considered if polyhydramnios and/or decreased fetal activity are observed on ultrasound examination in the third trimester.</p></div></div><div id="myotonic-d.Resources"><h2 id="_myotonic-d_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>MDF Clinic Visit Planner</b></div><div><i>Planner that enables families to discuss upcoming clinic visits and jot down important questions and information to help ensure that it was shared at the appointment.</i></div><div><a href="https://www.myotonic.org/sites/default/files/pages/files/MDF%20ClinicVisitPlannerv5.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MDF Clinic Visit Planner</a></div></li><li class="half_rhythm"><div><b>Myotonic Dystrophy: Making an Informed Choice About Genetic Testing</b></div><div><i>Booklet providing information about Myotonic Dystrophy and genetic testing (PDF file)</i></div><div>University of Washington Medical Center, Medical Genetics and Neurology</div><div>Seattle WA </div><div><a href="http://depts.washington.edu/neurolog/images/neurogenetics/myotonic.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">depts.washington.edu/neurolog/images/neurogenetics/myotonic.pdf</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=myotonicdystrophytype1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myotonic dystrophy</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22255/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myotonic dystrophy</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li><li class="half_rhythm"><div><b>Myotonic Dystrophy Family Registry (MDFR)</b></div><div><b>Phone:</b> 602-435-7496</div><div><b>Email:</b> coordinator@myotonicregistry.org</div><div><a href="https://myotonicregistry.patientcrossroads.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">myotonicregistry.patientcrossroads.org</a></div></li><li class="half_rhythm"><div><b>National Registry of Myotonic Dystrophy and FSHD Patients and Family Members</b></div><div>National Registry of Myotonic Dystrophy and FSHD</div><div>601 Elmwood Avenue</div><div>Box 673</div><div>Rochester NY 14642</div><div><b>Phone:</b> 888-925-4302</div><div><b>Fax:</b> 585-273-1255</div><div><b>Email:</b> dystrophy_registry@urmc.rochester.edu</div><div><a href="http://www.urmc.rochester.edu/neurology/national-registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">National Registry for Myotonic Dystrophy (DM) &#x00026; Facioscapulohumeral Dystrophy (FSHD)</a></div></li></ul></div><div id="myotonic-d.Molecular_Genetics"><h2 id="_myotonic-d_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="myotonic-d.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Myotonic Dystrophy Type 1: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1165/table/myotonic-d.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myotonic-d.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_myotonic-d.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_myotonic-d.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_myotonic-d.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_myotonic-d.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_myotonic-d.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_myotonic-d.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_myotonic-d.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1760" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>DMPK</i></a></td><td headers="hd_b_myotonic-d.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1760" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19q13<wbr style="display:inline-block"></wbr>​.32</a></td><td headers="hd_b_myotonic-d.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q09013" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myotonin-protein kinase</a></td><td headers="hd_b_myotonic-d.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/DMPK" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DMPK database</a></td><td headers="hd_b_myotonic-d.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=DMPK" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DMPK</a></td><td headers="hd_b_myotonic-d.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=DMPK[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DMPK</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="myotonic-d.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="myotonic-d.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Myotonic Dystrophy Type 1 (<a href="/omim/160900,605377" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1165/table/myotonic-d.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myotonic-d.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/160900" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">160900</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYOTONIC DYSTROPHY 1; DM1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605377" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605377</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>DMPK</i> has 14 exons covering approximately 13 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1165/#myotonic-d.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Normal alleles have 5-34 CTG repeats. Alleles with 35-49 CTG repeats are mutable normal (or <a class="def" href="/books/n/gene/glossary/def-item/premutation/">premutation</a>) alleles. Individuals with CTG expansions in the premutation range have not been reported to have symptoms, but their children are at increased risk of inheriting a larger repeat size and thus having symptoms [<a class="bk_pop" href="#myotonic-d.REF.martorell.2001.328">Martorell et al 2001</a>].</p><p><b>Pathogenic variants.</b> Myotonic dystrophy type 1 (DM1) appears to be caused by a single mutational mechanism: expanded CTG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> (&#x0003e;49). Other types of pathogenic variants (e.g., single-nucleotide variants, deletions, insertions) in <i>DMPK</i> have not been reported to be associated with DM1. The CTG repeat that is expanded in DM1 lies in the 3' untranslated region of <i>DMPK</i>. Abnormal repeat lengths may reach several thousand, particularly in individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> DM1.</p><div id="myotonic-d.T.dmpk_variants_discussed_in" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>DMPK</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1165/table/myotonic-d.T.dmpk_variants_discussed_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myotonic-d.T.dmpk_variants_discussed_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_myotonic-d.T.dmpk_variants_discussed_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant<br />Classification</th><th id="hd_h_myotonic-d.T.dmpk_variants_discussed_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_myotonic-d.T.dmpk_variants_discussed_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted<br />Protein Change</th><th id="hd_h_myotonic-d.T.dmpk_variants_discussed_in_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference<br />Sequences</th></tr></thead><tbody><tr><td headers="hd_h_myotonic-d.T.dmpk_variants_discussed_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Benign</b></td><td headers="hd_h_myotonic-d.T.dmpk_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.*224_226CTG(5-34)&#x000a0;<sup>1</sup><br />(normal range 5-34 CTG repeats)</td><td headers="hd_h_myotonic-d.T.dmpk_variants_discussed_in_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_myotonic-d.T.dmpk_variants_discussed_in_1_1_1_4" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001081563.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001081563<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/NP_001075032.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001075032<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_myotonic-d.T.dmpk_variants_discussed_in_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">c.*224_226CTG(35-49)&#x000a0;<sup>1</sup><br />(mutable normal range 35-49 CTG repeats)</td></tr><tr><td headers="hd_h_myotonic-d.T.dmpk_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_myotonic-d.T.dmpk_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.*224_226CTG(50-?)&#x000a0;<sup>1</sup><br />(full-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> mutated alleles &#x0003e;50 CTG repeats)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt></dt><dd><div><p class="no_margin">NA = not applicable</p></div></dd><dt>1. </dt><dd><div id="myotonic-d.TF.5.1"><p class="no_margin">The CTG variant is in the 3' untranslated region of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (indicated by *), with the first nucleotide after the stop codon numbered as *1. Parentheses indicate the range of numbers of the CTG repeats, here indicating that normal alleles range from 5 to 34 repeats. A specific single <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> with five repeats would be designated c.*224_226CTG[5].</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Myotonin-protein kinase (DMPK), a 69-kd serine-threonine protein kinase, has been localized to specialized cell structures in heart and skeletal muscle that are associated with intercellular conduction and impulse transmission. It is closely related to cyclic-AMP-dependent protein kinases and to Rho-binding kinases. DMPK may interact with a GTP-binding protein that is a regulatory subunit of myosin phosphatase.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The effect of the CTG repeat remains complex and many issues are being clarified [<a class="bk_pop" href="#myotonic-d.REF.fiszer.2013.683">Fiszer &#x00026; Krzyzosiak 2013</a>, <a class="bk_pop" href="#myotonic-d.REF.meola.2015.594">Meola &#x00026; Cardani 2015</a>, <a class="bk_pop" href="#myotonic-d.REF.thomas.2018.509">Thomas et al 2018</a>]. The effects of an expanded CTG repeat may occur via abnormal RNA transcript processing. Two homologous RNA CUG-binding proteins (CUG-BP and MBNL1 [muscleblind]) have been identified. These proteins are mutually antagonistic mediators of a subgroup of alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> events that are disrupted in DM, in which embryonic forms of some proteins now predominate. These proteins include: a chloride channel, resulting in myotonia; the insulin receptor, resulting in increased risk of diabetes mellitus; and microtubule-associated protein tau, encoded by <i>MAPT</i>, a gene associated with cognitive function [<a class="bk_pop" href="#myotonic-d.REF.savkur.2001.40">Savkur et al 2001</a>, <a class="bk_pop" href="#myotonic-d.REF.mankodi.2002.35">Mankodi et al 2002</a>, <a class="bk_pop" href="#myotonic-d.REF.kanadia.2003.1978">Kanadia et al 2003</a>, <a class="bk_pop" href="#myotonic-d.REF.ranum.2004.793">Ranum &#x00026; Day 2004</a>, <a class="bk_pop" href="#myotonic-d.REF.day.2005.5">Day &#x00026; Ranum 2005</a>, <a class="bk_pop" href="#myotonic-d.REF.cooper.2006.1825">Cooper 2006</a>, <a class="bk_pop" href="#myotonic-d.REF.leroy.2006.460">Leroy et al 2006</a>, <a class="bk_pop" href="#myotonic-d.REF.wheeler.2007.572">Wheeler &#x00026; Thornton 2007</a>, <a class="bk_pop" href="#myotonic-d.REF.carpentier.2014.654">Carpentier et al 2014</a>, <a class="bk_pop" href="#myotonic-d.REF.echeverria.2014.1893">Echeverria &#x00026; Cooper 2014</a>]. There is considerable <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> between various organs in DM1, which partially explains the wide phenotypic variability.</p></div><div id="myotonic-d.References"><h2 id="_myotonic-d_References_">References</h2><div id="myotonic-d.Published_Guidelines__Consens"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.ashizawa.2018.507">Ashizawa T, Gagnon C, Groh WJ, Gutmann L, et al.  Consensus-based care recommendations for adults with myotonic dystrophy type 1. <span><span class="ref-journal">Neurol Clin Pract. </span>2018;<span class="ref-vol">8</span>:507–20.</span> [<a href="/pmc/articles/PMC6294540/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6294540</span></a>] [<a href="/pubmed/30588381" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30588381</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF2">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 10-23-19. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.kamsteeg.2012.1203">Kamsteeg EJ, Kress W, Catalli C, Hertz JM, Witsch-Baumgartner M, Buckley MF, van Engelen BG, Schwartz M, Scheffer H. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. <span><span class="ref-journal">Eur J Hum Genet. </span>2012;<span class="ref-vol">20</span>:1203–8.</span> [<a href="/pmc/articles/PMC3499739/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3499739</span></a>] [<a href="/pubmed/22643181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22643181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF4">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset conditions. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2018. Accessed 10-23-19.</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.prior.2009">Prior TW. American College of Medical Genetics (ACMG) Laboratory Quality Assurance Committee technical standards and guidelines for myotonic dystrophy type 1 testing. Available <a href="https://www.nature.com/articles/gim200977" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2009. Accessed 10-23-19. [<a href="/pubmed/19546810" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19546810</span></a>]</div></li></ul></div><div id="myotonic-d.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.abbott.2016.783">Abbott D, Johnson NE, Cannon-Albright LA. A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy. <span><span class="ref-journal">Muscle Nerve. </span>2016;<span class="ref-vol">54</span>:783–5.</span> [<a href="/pmc/articles/PMC5824717/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5824717</span></a>] [<a href="/pubmed/27064430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27064430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.annane.2006.cd003218">Annane D, Moore DH, Barnes PR, Miller RG. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2006;<span class="ref-vol">3</span>:CD003218.</span> [<a href="/pubmed/16855999" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16855999</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.antonini.2006.181">Antonini G, Soscia F, Giubilei F, De Carolis A, Gragnani F, Morino S, Ruberto A, Tatarelli R. Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. <span><span class="ref-journal">J Rehabil Med. </span>2006;<span class="ref-vol">38</span>:181–5.</span> [<a href="/pubmed/16702085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16702085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.argov.2009.675">Argov Z, de Visser M. What we do not know about pregnancy in hereditary neuromuscular disorders. <span><span class="ref-journal">Neuromuscul Disord. </span>2009;<span class="ref-vol">19</span>:675–9.</span> [<a href="/pubmed/19692244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19692244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.arsenault.2006.1248">Arsenault ME, Prevost C, Lescault A, Laberge C, Puymirat J, Mathieu J. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">66</span>:1248–50.</span> [<a href="/pubmed/16636244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16636244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.ashizawa.2018.507_1">Ashizawa T, Gagnon C, Groh WJ, Gutmann L, et al.  Consensus-based care recommendations for adults with myotonic dystrophy type 1. <span><span class="ref-journal">Neurol Clin Pract. </span>2018;<span class="ref-vol">8</span>:507–20.</span> [<a href="/pmc/articles/PMC6294540/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6294540</span></a>] [<a href="/pubmed/30588381" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30588381</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.awater.2012.153">Awater C, Zerres K, Rudnik-Sch&#x000f6;neborn S. Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients. <span><span class="ref-journal">Eur J Obstet Gynecol Reprod Biol. </span>2012;<span class="ref-vol">162</span>:153–9.</span> [<a href="/pubmed/22459654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22459654</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.bae.2008.1120">Bae JS, Kim OK, Kim SJ, Kim BJ. Abnormalities of nerve conduction studies in myotonic dystrophy type 1: primary involvement of nerves or incidental coexistence? <span><span class="ref-journal">J Clin Neurosci. </span>2008;<span class="ref-vol">15</span>:1120–4.</span> [<a href="/pubmed/18657426" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18657426</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.bellini.2006.1821">Bellini M, Biagi S, Stasi C, Costa F, Mumolo MG, Ricchiuti A, Marchi S. Gastrointestinal manifestations in myotonic muscular dystrophy. <span><span class="ref-journal">World J Gastroenterol. </span>2006;<span class="ref-vol">12</span>:1821–8.</span> [<a href="/pmc/articles/PMC4087506/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4087506</span></a>] [<a href="/pubmed/16609987" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16609987</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.benhayon.2015.305">Benhayon D, Lugo R, Patel R, Carballeira L, Elman L, Cooper JM. Long-term arrhythmia follow-up of patients with myotonic dystrophy. <span><span class="ref-journal">J Cardiovasc Electrophysiol. </span>2015;<span class="ref-vol">26</span>:305–10.</span> [<a href="/pubmed/25546341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25546341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.bertrand.2015.49">Bertrand JA, Jean S, Laberge L, Gagnon C, Mathieu J, Gagnon JF, Richer L. Psychological characteristics of patients with myotonic dystrophy type 1. <span><span class="ref-journal">Acta Neurol Scand. </span>2015;<span class="ref-vol">132</span>:49–58.</span> [<a href="/pubmed/25496310" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25496310</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.bonanni.2018.414">Bonanni E, Carnicelli L, Crapanzano D, Maestri M, Simoncini C, Baldanzi S, Falorni M, Garbarino S, Mancuso M, Bonuccelli U, Siciliano G. Disruption of sleep-wake continuum in myotonic dystrophy type 1: beyond conventional sleep staging. <span><span class="ref-journal">Neuromuscul Disord. </span>2018;<span class="ref-vol">28</span>:414–21.</span> [<a href="/pubmed/29631952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29631952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.bouchard.2015.285">Bouchard JP, Cossette L, Bassez G, Puymirat J. Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases. <span><span class="ref-journal">J Neurol. </span>2015;<span class="ref-vol">262</span>:285–93.</span> [<a href="/pubmed/25380585" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25380585</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.boussa_d.2018.1075">Boussa&#x000ef;d G, Prigent H, Laforet P, Rapha&#x000eb;l JC, Annane D, Orlikowski D, Lofaso F. Effect and impact of mechanical ventilation in myotonic dystrophy type 1: a prospective cohort study. <span><span class="ref-journal">Thorax. </span>2018;<span class="ref-vol">73</span>:1075–8.</span> [<a href="/pubmed/29572271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29572271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.cailletboudin.2014.57">Caillet-Boudin ML, Fernandez-Gomez FJ, Tran H, Dhaenens CM, Buee L, Sergeant N. Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy. <span><span class="ref-journal">Front Mol Neurosci. </span>2014;<span class="ref-vol">6</span>:57.</span> [<a href="/pmc/articles/PMC3885824/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3885824</span></a>] [<a href="/pubmed/24409116" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24409116</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.campanati.2015.409">Campanati A, Giannoni M, Buratti L, Cagnetti C, Giuliodori K, Ganzetti G, Silvestrini M, Provinciali L, Offidani A. Skin features in myotonic dystrophy type 1: an observational study. <span><span class="ref-journal">Neuromuscul Disord. </span>2015;<span class="ref-vol">25</span>:409–13.</span> [<a href="/pubmed/25813338" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25813338</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.canavese.2009.208">Canavese F, Sussman MD. Orthopaedic manifestations of congenital myotonic dystrophy during childhood and adolescence. <span><span class="ref-journal">J Pediatr Orthop. </span>2009;<span class="ref-vol">29</span>:208–13.</span> [<a href="/pubmed/19352249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19352249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.carpentier.2014.654">Carpentier C, Ghanem D, Fernandez-Gomez FJ, Jumeau F, Philippe JV, Freyermuth F, Labudeck A, Eddarkaoui S, Dhaenens CM, Holt I, Behm-Ansmant I, Marmier-Gourrier N, Branlant C, Charlet-Berguerand N, Marie J, Schraen-Maschke S, Bu&#x000e9;e L, Sergeant N, Caillet-Boudin ML. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2. <span><span class="ref-journal">Biochim Biophys Acta. </span>2014;<span class="ref-vol">1842</span>:654–64.</span> [<a href="/pubmed/24440524" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24440524</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.caso.2014.e104697">Caso F, Agosta F, Peric S, Rako&#x0010d;evi&#x00107;-Stojanovi&#x00107; V, Copetti M, Kostic VS, Filippi M. Cognitive impairment in myotonic dystrophy type 1 is associated with white matter damage. <span><span class="ref-journal">PLoS One. </span>2014;<span class="ref-vol">9</span>:e104697.</span> [<a href="/pmc/articles/PMC4130603/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4130603</span></a>] [<a href="/pubmed/25115999" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25115999</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.cerghet.2008.930">Cerghet M, Tapos D, Serajee FJ, Mahbubul Huq AH. Homozygous myotonic dystrophy with craniosynostosis. <span><span class="ref-journal">J Child Neurol. </span>2008;<span class="ref-vol">23</span>:930–3.</span> [<a href="/pubmed/18474935" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18474935</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.chongnguyen.2017.10">Chong-Nguyen C, Wahbi K, Algalarrondo V, B&#x000e9;cane HM, Radvanyi-Hoffman H, Arnaud P, Furling D, Lazarus A, Bassez G, B&#x000e9;hin A, Fayssoil A, Lafor&#x000ea;t P, Stojkovic T, Eymard B, Duboc D. Association between mutation size and cardiac involvement in myotonic dystrophy type 1: an analysis of the DM1-heart registry. <span><span class="ref-journal">Circ Cardiovasc Genet. </span>2017:10.</span> [<a href="/pubmed/28611030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28611030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.cigliano.2005.673">Cigliano B, Baltogiannis N, De Marco M, Faviou E, Settimi A, Tilemis S, Soutis M, Papandreou E, D'Agostino S, Fabbro MA. Pilomatricoma in childhood: a retrospective study from three European paediatric centres. <span><span class="ref-journal">Eur J Pediatr. </span>2005;<span class="ref-vol">164</span>:673–7.</span> [<a href="/pubmed/16041525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16041525</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.cobo.1995.105">Cobo AM, Poza JJ, Martorell L, Lopez de Munain A, Emparanza JI, Baiget M. Contribution of molecular analyses to the estimation of the risk of congenital myotonic dystrophy. <span><span class="ref-journal">J Med Genet. </span>1995;<span class="ref-vol">32</span>:105–8.</span> [<a href="/pmc/articles/PMC1050229/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050229</span></a>] [<a href="/pubmed/7760317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7760317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.cooper.2006.1825">Cooper TA. A reversal of misfortune for myotonic dystrophy? <span><span class="ref-journal">N Engl J Med. </span>2006;<span class="ref-vol">355</span>:1825–7.</span> [<a href="/pubmed/17065646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17065646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.cudia.2009.790">Cudia P, Bernasconi P, Chiodelli R, Mangiola F, Bellocci F, Dello Russo A, Angelini C, Romeo V, Melacini P, Politano L, Palladino A, Nigro G, Siciliano G, Falorni M, Bongiorni MG, Falcone C, Mantegazza R, Morandi L. Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2009;<span class="ref-vol">80</span>:790–3.</span> [<a href="/pubmed/19237383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19237383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.cumming.2019.e995">Cumming SA, Jimenez-Moreno C, Okkersen K, Wenninger S, Daidj F, Hogarth F, Littleford R, Gorman G, Bassez G, Schoser B, Lochm&#x000fc;ller H, van Engelen BGM, Monckton DG, et al.  Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort. <span><span class="ref-journal">Neurology. </span>2019;<span class="ref-vol">93</span>:e995–1009.</span> [<a href="/pmc/articles/PMC6745735/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6745735</span></a>] [<a href="/pubmed/31395669" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31395669</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.dauvilliers.2012.539">Dauvilliers YA, Laberge L. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation. <span><span class="ref-journal">Sleep Med Rev. </span>2012;<span class="ref-vol">16</span>:539–45.</span> [<a href="/pubmed/22465566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22465566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.day.2005.5">Day JW, Ranum LP. RNA pathogenesis of the myotonic dystrophies. <span><span class="ref-journal">Neuromuscul Disord. </span>2005;<span class="ref-vol">15</span>:5–16.</span> [<a href="/pubmed/15639115" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15639115</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.de_diesmulders.1998.1557">de Die-Smulders CE, Howeler CJ, Thijs C, Mirandolle JF, Anten HB, Smeets HJ, Chandler KE, Geraedts JP. Age and causes of death in adult-onset myotonic dystrophy. <span><span class="ref-journal">Brain. </span>1998;<span class="ref-vol">121</span>:1557–63.</span> [<a href="/pubmed/9712016" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9712016</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.de_swart.2004.1480">de Swart BJ, van Engelen BG, van de Kerkhof JP, Maassen BA. Myotonia and flaccid dysarthria in patients with adult onset myotonic dystrophy. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2004;<span class="ref-vol">75</span>:1480–2.</span> [<a href="/pmc/articles/PMC1738733/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1738733</span></a>] [<a href="/pubmed/15377703" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15377703</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.dean.2006.299">Dean NL, Loredo-Osti JC, Fujiwara TM, Morgan K, Tan SL, Naumova AK, Ao A. Transmission ratio distortion in the myotonic dystrophy locus in human preimplantation embryos. <span><span class="ref-journal">Eur J Hum Genet. </span>2006;<span class="ref-vol">14</span>:299–306.</span> [<a href="/pubmed/16391559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16391559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.delaporte.1998.635">Delaporte C. Personality patterns in patients with myotonic dystrophy. <span><span class="ref-journal">Arch Neurol. </span>1998;<span class="ref-vol">55</span>:635–40.</span> [<a href="/pubmed/9605719" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9605719</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.douniol.2012.905">Douniol M, Jacquette A, Cohen D, Bodeau N, Rachidi L, Angeard N, Cuisset JM, Vall&#x000e9;e L, Eymard B, Plaza M, H&#x000e9;ron D, Guil&#x000e9; JM. Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1. <span><span class="ref-journal">Dev Med Child Neurol. </span>2012;<span class="ref-vol">54</span>:905–11.</span> [<a href="/pubmed/22861906" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22861906</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.echeverria.2014.1893">Echeverria GV, Cooper TA. Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron. <span><span class="ref-journal">Nucleic Acids Res. </span>2014;<span class="ref-vol">42</span>:1893–903.</span> [<a href="/pmc/articles/PMC3919616/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3919616</span></a>] [<a href="/pubmed/24185704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24185704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.ekstr_m.2008.918">Ekstr&#x000f6;m AB, Haken&#x000e4;s-Plate L, Samuelsson L, Tulinius M, Wentz E. Autism spectrum conditions in myotonic dystrophy type 1: a study on 57 individuals with congenital and childhood forms. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2008;<span class="ref-vol">147B</span>:918–26.</span> [<a href="/pubmed/18228241" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18228241</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.ekstr_m.2009.982">Ekstr&#x000f6;m AB, Haken&#x000e4;s-Plate L, Tulinius M, Wentz E. Cognition and adaptive skills in myotonic dystrophy type 1: a study of 55 individuals with congenital and childhood forms. <span><span class="ref-journal">Dev Med Child Neurol. </span>2009;<span class="ref-vol">51</span>:982–90.</span> [<a href="/pubmed/19459914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19459914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.ekstr_m.2010.976">Ekstr&#x000f6;m AB, Tulinius M, Sj&#x000f6;str&#x000f6;m A, Aring E. Visual function in congenital and childhood myotonic dystrophy type 1. <span><span class="ref-journal">Ophthalmology. </span>2010;<span class="ref-vol">117</span>:976–82.</span> [<a href="/pubmed/20346513" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20346513</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.emparanza.2018.517">Emparanza JI, L&#x000f3;pez de Munain A, Greene MH, Matheu A, Fern&#x000e1;ndez-Torr&#x000f3;n R, Gadalla SM. Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis. <span><span class="ref-journal">Muscle Nerve. </span>2018;<span class="ref-vol">58</span>:517–22.</span> [<a href="/pmc/articles/PMC6173974/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6173974</span></a>] [<a href="/pubmed/30028904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30028904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.engvall.2009.412">Engvall M, Sj&#x000f6;green L, Kjellberg H, Robertson A, Sundell S, Kiliaridis S. Oral health status in a group of children and adolescents with myotonic dystrophy type 1 over a 4-year period. <span><span class="ref-journal">Int J Paediatr Dent. </span>2009;<span class="ref-vol">19</span>:412–22.</span> [<a href="/pubmed/19732192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19732192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.ercolin.2013.446">Ercolin B, Sassi FC, Mangilli LD, Mendon&#x000e7;a LI, Limongi SC, de Andrade CR. Oral motor movements and swallowing in patients with myotonic dystrophy type 1. <span><span class="ref-journal">Dysphagia. </span>2013;<span class="ref-vol">28</span>:446–54.</span> [<a href="/pubmed/23460343" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23460343</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.facendalorenzo.2013.193">Facenda-Lorenzo M, Hern&#x000e1;ndez-Afonso J, Rodr&#x000ed;guez-Esteban M, de Le&#x000f3;n-Hern&#x000e1;ndez JC, Grillo-P&#x000e9;rez JJ. Cardiac manifestations in myotonic dystrophy type 1 patients followed using a standard protocol in a specialized unit. <span><span class="ref-journal">Rev Esp Cardiol. </span>2013;<span class="ref-vol">66</span>:193–7.</span> [<a href="/pubmed/24775453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24775453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.fern_ndez.2017.9165363">Fern&#x000e1;ndez RM, Lozano-Arana MD, S&#x000e1;nchez B, Peci&#x000f1;a A, Garc&#x000ed;a-Lozano JC, Borrego S, Anti&#x000f1;olo G. Preimplantation genetic diagnosis for myotonic dystrophy type 1 and analysis of the effect of the disease on the reproductive outcome of the affected female patients. <span><span class="ref-journal">Biomed Res Int. </span>2017;<span class="ref-vol">2017</span>:9165363.</span> [<a href="/pmc/articles/PMC5733891/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5733891</span></a>] [<a href="/pubmed/29349085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29349085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.fiszer.2013.683">Fiszer A, Krzyzosiak WJ. RNA toxicity in polyglutamine disorders: concepts, models, and progress of research. <span><span class="ref-journal">J Mol Med (Berl). </span>2013;<span class="ref-vol">91</span>:683–91.</span> [<a href="/pmc/articles/PMC3659269/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3659269</span></a>] [<a href="/pubmed/23512265" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23512265</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.fujino.2018.742">Fujino H, Shingaki H, Suwazono S, Ueda Y, Wada C, Nakayama T, Takahashi MP, Imura O, Matsumura T. Cognitive impairment and quality of life in patients with myotonic dystrophy type 1. <span><span class="ref-journal">Muscle Nerve. </span>2018;<span class="ref-vol">57</span>:742–8.</span> [<a href="/pubmed/29193182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29193182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.gagnon.2013.42">Gagnon C, Chouinard MC, Laberge L, Brisson D, Gaudet D, Lavoie M, Leclerc N, Mathieu J. Prevalence of lifestyle risk factors in myotonic dystrophy type 1. <span><span class="ref-journal">Can J Neurol Sci. </span>2013;<span class="ref-vol">40</span>:42–7.</span> [<a href="/pubmed/23250126" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23250126</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.garrott.2004.653">Garrott HM, Walland MJ, O'Day J. Recurrent posterior capsular opacification and capsulorhexis contracture after cataract surgery in myotonic dystrophy. <span><span class="ref-journal">Clin Experiment Ophthalmol. </span>2004;<span class="ref-vol">32</span>:653–5.</span> [<a href="/pubmed/15575838" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15575838</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.glaser.2015.424">Glaser AM, Johnston JH, Gleason WA, Rhoads JM. Myotonic dystrophy as a cause of colonic pseudoobstruction: not just another constipated child. <span><span class="ref-journal">Clin Case Rep. </span>2015;<span class="ref-vol">3</span>:424–6.</span> [<a href="/pmc/articles/PMC4498855/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4498855</span></a>] [<a href="/pubmed/26185641" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26185641</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.gorelik.2018.243">Gorelik L, Flores A. Anesthetic management for multiple family members with myotonic dystrophy for interventional cardiac procedures-a case series. <span><span class="ref-journal">Front Med (Lausanne). </span>2018;<span class="ref-vol">4</span>:243.</span> [<a href="/pmc/articles/PMC5766654/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5766654</span></a>] [<a href="/pubmed/29359132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29359132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.groh.2011.648">Groh WJ, Groh MR, Shen C, Monckton DG, Bodkin CL, Pascuzzi RM. Survival and CTG repeat expansion in adults with myotonic dystrophy type 1. <span><span class="ref-journal">Muscle Nerve. </span>2011;<span class="ref-vol">43</span>:648–51.</span> [<a href="/pubmed/21484823" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21484823</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.harper.2001">Harper PS. <em>Major Problems in Neurology: Myotonic Dystrophy.</em> London, UK: WB Saunders; 2001.</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.hilbert.2017.1348">Hilbert JE, Barohn RJ, Clemens PR, Luebbe EA, Martens WB, McDermott MP, Parkhill AL, Tawil R, Thornton CA, Moxley RT 3rd., National Registry Scientific Advisory Committee/Investigators.  High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2. <span><span class="ref-journal">Neurology. </span>2017;<span class="ref-vol">89</span>:1348–54.</span> [<a href="/pmc/articles/PMC5649763/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5649763</span></a>] [<a href="/pubmed/28855409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28855409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.heatwole.2006.1149">Heatwole CR, Miller J, Martens B, Moxley RT 3rd. Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1. <span><span class="ref-journal">Arch Neurol. </span>2006;<span class="ref-vol">63</span>:1149–53.</span> [<a href="/pubmed/16908743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16908743</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.ho.2017.92">Ho G, Widger J, Cardamone M, Farrar MA. Quality of life and excessive daytime sleepiness in children and adolescents with myotonic dystrophy type 1. <span><span class="ref-journal">Sleep Med. </span>2017;<span class="ref-vol">32</span>:92–6.</span> [<a href="/pubmed/28366348" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28366348</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.international_myotonic_dystrophy_consortium.2000.1218">International Myotonic Dystrophy Consortium.  New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC). <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">54</span>:1218–21.</span> [<a href="/pubmed/10746587" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10746587</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.jacobs.2017.359">Jacobs D, Willekens D, de Die-Smulders C, Frijns JP, Steyaert J. Delusional and psychotic disorders in juvenile myotonic dystrophy type-1. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2017;<span class="ref-vol">174</span>:359–66.</span> [<a href="/pubmed/28449271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28449271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.jean.2014.186">Jean S, Richer L, Laberge L, Mathieu J. Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1). <span><span class="ref-journal">Orphanet J Rare Dis. </span>2014;<span class="ref-vol">9</span>:186.</span> [<a href="/pmc/articles/PMC4247010/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4247010</span></a>] [<a href="/pubmed/25424323" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25424323</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.jim_nezmoreno.2018.229">Jim&#x000e9;nez-Moreno AC, Raaphorst J, Baba&#x0010d;i&#x00107; H, Wood L, van Engelen B, Lochm&#x000fc;ller H, Schoser B, Wenninger S. Falls and resulting fractures in myotonic dystrophy: results from a multinational retrospective survey. <span><span class="ref-journal">Neuromuscul Disord. </span>2018;<span class="ref-vol">28</span>:229–35.</span> [<a href="/pubmed/29361394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29361394</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.johnson.2015.659">Johnson NE, Abbott D, Cannon-Albright LA. Relative risks for comorbidities associated with myotonic dystrophy: a population-based analysis. <span><span class="ref-journal">Muscle Nerve. </span>2015;<span class="ref-vol">52</span>:659–61.</span> [<a href="/pmc/articles/PMC4580516/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4580516</span></a>] [<a href="/pubmed/26172955" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26172955</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.johnson.2019.1">Johnson NE, Aldana EZ, Angeard N, Ashizawa T, Berggren KN, Marini-Bettolo C, Duong I, Ekstr&#x000f6;m AB, Sansone V, Tian C, Hellerstein L, Campbell C. Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1. <span><span class="ref-journal">Neurol Clin Pract. </span>2019;<span class="ref-vol">9</span>:1–12.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.johnson.2016.160">Johnson NE, Butterfield R, Berggren K, Hung M, Chen W, DiBella D, Dixon M, Hayes H, Pucillo E, Bounsanga J, Heatwole C, Campbell C. Disease burden and functional outcomes in congenital myotonic dystrophy: a cross-sectional study. <span><span class="ref-journal">Neurology. </span>2016;<span class="ref-vol">87</span>:160–7.</span> [<a href="/pmc/articles/PMC4940062/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4940062</span></a>] [<a href="/pubmed/27306634" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27306634</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.kalkman.2005.1406">Kalkman JS, Schillings ML, van der Werf SP, Padberg GW, Zwarts MJ, van Engelen BG, Bleijenberg G. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2005;<span class="ref-vol">76</span>:1406–9.</span> [<a href="/pmc/articles/PMC1739364/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1739364</span></a>] [<a href="/pubmed/16170086" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16170086</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.kamsteeg.2012.1203_1">Kamsteeg EJ, Kress W, Catalli C, Hertz JM, Witsch-Baumgartner M, Buckley MF, van Engelen BG, Schwartz M, Scheffer H. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. <span><span class="ref-journal">Eur J Hum Genet. </span>2012;<span class="ref-vol">20</span>:1203–8.</span> [<a href="/pmc/articles/PMC3499739/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3499739</span></a>] [<a href="/pubmed/22643181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22643181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.kanadia.2003.1978">Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS. A muscleblind knockout model for myotonic dystrophy. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">302</span>:1978–80.</span> [<a href="/pubmed/14671308" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14671308</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.kierkegaard.2011.695">Kierkegaard M, Harms-Ringdahl K, Edstr&#x000f6;m L, Wid&#x000e9;n Holmqvist L, Tollb&#x000e4;ck A. Feasibility and effects of a physical exercise programme in adults with myotonic dystrophy type 1: a randomized controlled pilot study. <span><span class="ref-journal">J Rehabil Med. </span>2011;<span class="ref-vol">43</span>:695–702.</span> [<a href="/pubmed/21670942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21670942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.kirzinger.2010.842">Kirzinger L, Schmidt A, Kornblum C, Schneider-Gold C, Kress W, Schoser B. Side effects of anesthesia in DM2 as compared to DM1: a comparative retrospective study. <span><span class="ref-journal">Eur J Neurol. </span>2010;<span class="ref-vol">17</span>:842–5.</span> [<a href="/pubmed/20100232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20100232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.kroksmark.2017.826">Kroksmark AK, Stridh ML, Ekstr&#x000f6;m AB. Long-term follow-up of motor function and muscle strength in the congenital and childhood forms of myotonic dystrophy type 1. <span><span class="ref-journal">Neuromuscul Disord. </span>2017;<span class="ref-vol">27</span>:826–35.</span> [<a href="/pubmed/28673557" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28673557</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.kumar.2007.15">Kumar SP, Sword D, Petty RK, Banham SW, Patel KR. Assessment of sleep studies in myotonic dystrophy. <span><span class="ref-journal">Chron Respir Dis. </span>2007;<span class="ref-vol">4</span>:15–8.</span> [<a href="/pubmed/17416148" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17416148</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.laberge.2009.642">Laberge L, B&#x000e9;gin P, Dauvilliers Y, Beaudry M, Laforte M, Jean S, Mathieu J. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2009;<span class="ref-vol">80</span>:642–6.</span> [<a href="/pubmed/19211594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19211594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.lau.2015.600">Lau JK, Sy RW, Corbett A, Kritharides L. Myotonic dystrophy and the heart: a systematic review of evaluation and management. <span><span class="ref-journal">Int J Cardiol. </span>2015;<span class="ref-vol">184</span>:600–8.</span> [<a href="/pubmed/25769007" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25769007</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.le_ber.2004.1979">Le Ber I, Martinez M, Campion D, Laquerriere A, Betard C, Bassez G, Girard C, Saugier-Veber P, Raux G, Sergeant N, Magnier P, Maisonobe T, Eymard B, Duyckaerts C, Delacourte A, Frebourg T, Hannequin D. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24. <span><span class="ref-journal">Brain. </span>2004;<span class="ref-vol">127</span>:1979–92.</span> [<a href="/pubmed/15215218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15215218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.leroy.2006.460">Leroy O, Wang J, Maurage CA, Parent M, Cooper T, Bu&#x000e9;e L, Sergeant N, Andreadis A, Caillet-Boudin ML. Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1. <span><span class="ref-journal">Biochim Biophys Acta. </span>2006;2006;<span class="ref-vol">1762</span>:460–7.</span> [<a href="/pubmed/16487687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16487687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.logigian.2005.35">Logigian EL, Blood CL, Dilek N, Martens WB, Moxley RT 4th, Wiegner AW, Thornton CA, Moxley RT 3rd. Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1. <span><span class="ref-journal">Muscle Nerve. </span>2005;<span class="ref-vol">32</span>:35–42.</span> [<a href="/pubmed/15880468" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15880468</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.logigian.2010.1441">Logigian EL, Martens WB, Moxley RT 4th, McDermott MP, Dilek N, Wiegner AW, Pearson AT, Barbieri CA, Annis CL, Thornton CA, Moxley RT 3rd. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. <span><span class="ref-journal">Neurology. </span>2010;2010;<span class="ref-vol">74</span>:1441–8.</span> [<a href="/pmc/articles/PMC2871004/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2871004</span></a>] [<a href="/pubmed/20439846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20439846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.logigian.2004.1081">Logigian EL, Moxley RT 4th, Blood CL, Barbieri CA, Martens WB, Wiegner AW, Thornton CA, Moxley RT 3rd. Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:1081–9.</span> [<a href="/pubmed/15079005" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15079005</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.lund.2014.1192">Lund M, Diaz LJ, G&#x000f8;rtz S, Feenstra B, Duno M, Juncker I, Eiberg H, Vissing J, Wohlfahrt J, Melbye M. Risk of cancer in relatives of patients with myotonic dystrophy: a population-based cohort study. <span><span class="ref-journal">Eur J Neurol. </span>2014;<span class="ref-vol">21</span>:1192–7.</span> [<a href="/pubmed/24838088" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24838088</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.mankodi.2002.35">Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, Cannon SC, Thornton CA. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. <span><span class="ref-journal">Mol Cell. </span>2002;<span class="ref-vol">10</span>:35–44.</span> [<a href="/pubmed/12150905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12150905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.marcoval.2016.700">Marcoval J, Oliv&#x000e9; M, Bonfill-Ort&#x000ed; M, Mart&#x000ed;nez-Molina L, Talavera-Belmonte A. Cutaneous neoplasms in myotonic dystrophy type 1. <span><span class="ref-journal">Dermatology. </span>2016;<span class="ref-vol">232</span>:700–3.</span> [<a href="/pubmed/28249295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28249295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.martorell.2007.68">Martorell L, Cobo AM, Baiget M, Naud&#x000f3; M, Poza JJ, Parra J. Prenatal diagnosis in myotonic dystrophy type 1. Thirteen years of experience: implications for reproductive counselling in DM1 families. <span><span class="ref-journal">Prenat Diagn. </span>2007;2007;<span class="ref-vol">27</span>:68–72.</span> [<a href="/pubmed/17154336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17154336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.martorell.2001.328">Martorell L, Monckton DG, Sanchez A, Lopez De Munain A, Baiget M. Frequency and stability of the myotonic dystrophy type 1 premutation. <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">56</span>:328–35.</span> [<a href="/pubmed/11171897" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11171897</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.mathieu.1997.1646">Mathieu J, Allard P, Gobeil G, Girard M, De Braekeleer M, Begin P. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. <span><span class="ref-journal">Neurology. </span>1997;<span class="ref-vol">49</span>:1646–50.</span> [<a href="/pubmed/9409361" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9409361</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.mathieu.1999.1658">Mathieu J, Allard P, Potvin L, Prevost C, Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">52</span>:1658–62.</span> [<a href="/pubmed/10331695" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10331695</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.matsumura.2009.60">Matsumura T, Iwahashi H, Funahashi T, Takahashi MP, Saito T, Yasui K, Saito T, Iyama A, Toyooka K, Fujimura H, Shinno S. A cross-sectional study for glucose intolerance of myotonic dystrophy. <span><span class="ref-journal">J Neurol Sci. </span>2009;<span class="ref-vol">276</span>:60–5.</span> [<a href="/pubmed/18834994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18834994</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.meola.2015.594">Meola G, Cardani R. Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms. <span><span class="ref-journal">Biochim Biophys Acta. </span>2015;<span class="ref-vol">1852</span>:594–606.</span> [<a href="/pubmed/24882752" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24882752</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.mladenovic.2006.451">Mladenovic J, Pekmezovic T, Todorovic S, Rakocevic-Stojanovic V, Savic D, Romac S, Apostolski S. Survival and mortality of myotonic dystrophy type 1 (Steinert's disease) in the population of Belgrade. <span><span class="ref-journal">Eur J Neurol. </span>2006;<span class="ref-vol">13</span>:451–4.</span> [<a href="/pubmed/16722967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16722967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.modoni.2008.1737">Modoni A, Silvestri G, Vita MG, Quaranta D, Tonali PA, Marra C. Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study. <span><span class="ref-journal">J Neurol. </span>2008;<span class="ref-vol">255</span>:1737–42.</span> [<a href="/pubmed/18821050" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18821050</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.montella.2005.192">Montella L, Caraglia M, Addeo R, Costanzo R, Faiola V, Abbruzzese A, Del Prete S. Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert's disease). <span><span class="ref-journal">Ann Hematol. </span>2005;<span class="ref-vol">84</span>:192–3.</span> [<a href="/pubmed/15042318" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15042318</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.motlagh.2005.713">Motlagh B, MacDonald JR, Tarnopolsky MA. Nutritional inadequacy in adults with muscular dystrophy. <span><span class="ref-journal">Muscle Nerve. </span>2005;<span class="ref-vol">31</span>:713–8.</span> [<a href="/pubmed/15786416" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15786416</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.moxley.2008">Moxley RT, Meola G. The myotonic dystrophies. In: <em>The Molecular and Genetic Basis of Neurologic and Psychiatric Disease</em>. Rosenberg RN, DiMauro S, Paulson HL, Ptacek L, Nestler EJ, eds. Philadelphia, PA: Wolters Kluwer; 2008:532-41.</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.nishi.2004.1216">Nishi M, Itoh H, Tsubokawa T, Taniguchi T, Yamamoto K. Effective doses of vecuronium in a patient with myotonic dystrophy. <span><span class="ref-journal">Anaesthesia. </span>2004;<span class="ref-vol">59</span>:1216–8.</span> [<a href="/pubmed/15549982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15549982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.okkersen.2017.960">Okkersen K, Monckton DG, Le N, Tuladhar AM, Raaphorst J, van Engelen BGM. Brain imaging in myotonic dystrophy type 1: a systematic review. <span><span class="ref-journal">Neurology. </span>2017;<span class="ref-vol">89</span>:960–9.</span> [<a href="/pubmed/28768849" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28768849</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF._rngreen.2012.912">&#x000d8;rngreen MC, Arlien-S&#x000f8;borg P, Duno M, Hertz JM, Vissing J. Endocrine function in 97 patients with myotonic dystrophy type 1. <span><span class="ref-journal">J Neurol. </span>2012;<span class="ref-vol">259</span>:912–20.</span> [<a href="/pubmed/22349862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22349862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.parisi.2007.227">Parisi M, Galderisi M, Sidiropulos M, Fiorillo C, Lanzillo R, D'Errico A, Grieco M, Innelli P, Santoro L, de Divitiis O. Early detection of biventricular involvement in myotonic dystrophy by tissue Doppler. <span><span class="ref-journal">Int J Cardiol. </span>2007;<span class="ref-vol">118</span>:227–32.</span> [<a href="/pubmed/17045670" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17045670</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.passeri.2013.132">Passeri E, Bugiardini E, Sansone VA, Valaperta R, Costa E, Ambrosi B, Meola G, Corbetta S. Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies. <span><span class="ref-journal">J Neurol Sci. </span>2013;<span class="ref-vol">331</span>:132–5.</span> [<a href="/pubmed/23809192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23809192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.peric.2014.219">Peric S, Sreckov M, Basta I, Lavrnic D, Vujnic M, Marjanovic I, Rakocevic Stojanovic V. Dependent and paranoid personality patterns in myotonic dystrophy type 1. <span><span class="ref-journal">Acta Neurol Scand. </span>2014;<span class="ref-vol">129</span>:219–25.</span> [<a href="/pubmed/24032453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24032453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.peric.2013.331">Peric S, Stojanovic VR, Nikolic A, Kacar A, Basta I, Pavlovic S, Lavrnic D. Peripheral neuropathy in patients with myotonic dystrophy type 1. <span><span class="ref-journal">Neurol Res. </span>2013;<span class="ref-vol">35</span>:331–5.</span> [<a href="/pubmed/23336676" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23336676</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.pincherle.2012.219">Pincherle A, Patruno V, Raimondi P, Moretti S, Dominese A, Martinelli-Boneschi F, Pasanisi MB, Canioni E, Salerno F, Deleo F, Spreafico R, Mantegazza R, Villani F, Morandi L. Sleep breathing disorders in 40 Italian patients with Myotonic dystrophy type 1. <span><span class="ref-journal">Neuromuscul Disord. </span>2012;<span class="ref-vol">22</span>:219–24.</span> [<a href="/pubmed/22137426" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22137426</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.pratte.2015.708">Pratte A, Pr&#x000e9;vost C, Puymirat J, Mathieu J. Anticipation in myotonic dystrophy type 1 parents with small CTG expansions. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:708–14.</span> [<a href="/pubmed/25712547" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25712547</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.prior.2009.552">Prior TW. American College of Medical Genetics (ACMG) Laboratory Quality Assurance Committee Technical standards and guidelines for myotonic dystrophy type 1 testing. <span><span class="ref-journal">Genet Med. </span>2009;<span class="ref-vol">11</span>:552–5.</span> [<a href="/pubmed/19546810" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19546810</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.rakocevi_stojanovi_.2005.236">Rakocevi&#x00107;-Stojanovi&#x00107; V, Savi&#x00107; D, Pavlovi&#x00107; S, Lavrni&#x00107; D, Stevi&#x00107; Z, Basta I, Romac S, Apostolski S. Intergenerational changes of CTG repeat depending on the sex of the transmitting parent in myotonic dystrophy type 1. <span><span class="ref-journal">Eur J Neurol. </span>2005;<span class="ref-vol">12</span>:236–7.</span> [<a href="/pubmed/15693817" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15693817</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.ranum.2004.793">Ranum LP, Day JW. Myotonic dystrophy: RNA pathogenesis comes into focus. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">74</span>:793–804.</span> [<a href="/pmc/articles/PMC1181975/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1181975</span></a>] [<a href="/pubmed/15065017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15065017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.raymond.2017.673">Raymond K, Levasseur M, Mathieu J, Desrosiers J, Gagnon C. A 9-year follow-up study of the natural progression of upper limb performance in myotonic dystrophy type 1: a similar decline for phenotypes but not for gender. <span><span class="ref-journal">Neuromuscul Disord. </span>2017;<span class="ref-vol">27</span>:673–82.</span> [<a href="/pubmed/28527585" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28527585</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.redman.1993.1960">Redman JB, Fenwick RG Jr, Fu YH, Pizzuti A, Caskey CT. Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. <span><span class="ref-journal">JAMA. </span>1993;<span class="ref-vol">269</span>:1960–5.</span> [<a href="/pubmed/8464127" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8464127</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.ricker.1999.170">Ricker K, Grimm T, Koch MC, Schneider C, Kress W, Reimers CD, Schulte-Mattler W, Mueller-Myhsok B, Toyka KV, Mueller CR. Linkage of proximal myotonic myopathy to chromosome 3q. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">52</span>:170–1.</span> [<a href="/pubmed/9921867" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9921867</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.r_nnblom.1996.654">R&#x000f6;nnblom A, Forsberg H, Danielsson A. Gastrointestinal symptoms in myotonic dystrophy. <span><span class="ref-journal">Scand J Gastroenterol. </span>1996;<span class="ref-vol">31</span>:654–7.</span> [<a href="/pubmed/8819213" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8819213</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.roses.1997">Roses AD. Myotonic dystrophy. In: Rosenberg RN, Prusiner SB, Dimauro S, Barchi RL, eds. <em>The Molecular and Genetic Basis of Neurological Disease</em>. 2 ed. Stoneham, MA: Butterworth-Heinemann; 1997.</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.rubinsztein.1998.510">Rubinsztein JS, Rubinsztein DC, Goodburn S, Holland AJ. Apathy and hypersomnia are common features of myotonic dystrophy. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>1998;<span class="ref-vol">64</span>:510–5.</span> [<a href="/pmc/articles/PMC2170039/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2170039</span></a>] [<a href="/pubmed/9576545" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9576545</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.russo.2018.327">Russo V, Papa AA, Rago A, Ciardiello C, Marano M, Proietti R, Politano L, Nigro G. Interatrial block to predict atrial fibrillation in myotonic dystrophy type 1. <span><span class="ref-journal">Neuromuscul Disord. </span>2018;<span class="ref-vol">28</span>:327–33.</span> [<a href="/pubmed/29567351" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29567351</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.s_.2007.745">S&#x000e1; MI, Cabral S, Costa PD, Coelho T, Freitas M, Gomes JL. Ambulatory electrocardiographic monitoring in type 1 myotonic dystrophy. <span><span class="ref-journal">Rev Port Cardiol. </span>2007;2007;<span class="ref-vol">26</span>:745–53.</span> [<a href="/pubmed/17939583" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17939583</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.savkur.2001.40">Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:40–7.</span> [<a href="/pubmed/11528389" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11528389</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.sistiaga.2010.487">Sistiaga A, Urreta I, Jodar M, Cobo AM, Emparanza J, Otaegui D, Poza JJ, Merino JJ, Imaz H, Mart&#x000ed;-Mass&#x000f3; JF, L&#x000f3;pez de Munain A. Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1. <span><span class="ref-journal">Psychol Med. </span>2010;<span class="ref-vol">40</span>:487–95.</span> [<a href="/pubmed/19627641" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19627641</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.sochala.2017.175">Sochala M, Wahbi K, Sorbets E, Lazarus A, B&#x000e9;cane HM, Stojkovic T, Fayssoil A, Lafor&#x000ea;t P, B&#x000e9;hin A, Sroussi M, Eymard B, Duboc D, Meune C. Risk for complications after pacemaker or cardioverter defibrillator implantations in patients with myotonic dystrophy type 1. <span><span class="ref-journal">J Neuromuscul Dis. </span>2017;<span class="ref-vol">4</span>:175–81.</span> [<a href="/pubmed/28598855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28598855</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.sovari.2007.191">Sovari AA, Bodine CK, Farokhi F. Cardiovascular manifestations of myotonic dystrophy-1. <span><span class="ref-journal">Cardiol Rev. </span>2007;<span class="ref-vol">15</span>:191–4.</span> [<a href="/pubmed/17575483" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17575483</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.takado.2015.247">Takado Y, Terajima K, Ohkubo M, Okamoto K, Shimohata T, Nishizawa M, Igarashi H, Nakada T. Diffuse brain abnormalities in myotonic dystrophy type 1 detected by 3.0 T proton magnetic resonance spectroscopy. <span><span class="ref-journal">Eur Neurol. </span>2015;<span class="ref-vol">73</span>:247–56.</span> [<a href="/pubmed/25824277" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25824277</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.talbot.2003.357">Talbot K, Stradling J, Crosby J, Hilton-Jones D. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy. <span><span class="ref-journal">Neuromuscul Disord. </span>2003;<span class="ref-vol">13</span>:357–64.</span> [<a href="/pubmed/12798791" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12798791</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.theadom.2014.259">Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, Jones K, Krishnamurthi R, Feigin V. Prevalence of muscular dystrophies: a systematic literature review. <span><span class="ref-journal">Neuroepidemiology. </span>2014;<span class="ref-vol">43</span>:259–68.</span> [<a href="/pubmed/25532075" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25532075</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.thil.2017.816">Thil C, Agrinier N, Chenuel B, Poussel M. Longitudinal course of lung function in myotonic dystrophy type 1. <span><span class="ref-journal">Muscle Nerve. </span>2017;<span class="ref-vol">56</span>:816–18.</span> [<a href="/pubmed/28181267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28181267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.thomas.2018.509">Thomas JD, Oliveira R, Sznajder &#x00141;J, Swanson MS. Myotonic dystrophy and developmental regulation of RNA processing. <span><span class="ref-journal">Compr Physiol. </span>2018;<span class="ref-vol">8</span>:509–53.</span> [<a href="/pubmed/29687899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29687899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.thornton.2014.705">Thornton CA. Myotonic dystrophy. <span><span class="ref-journal">Neurol Clin. </span>2014;<span class="ref-vol">32</span>:705–19.</span> [<a href="/pmc/articles/PMC4105852/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4105852</span></a>] [<a href="/pubmed/25037086" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25037086</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.turner.2014.599">Turner C, Hilton-Jones D. Myotonic dystrophy: diagnosis, management and new therapies. <span><span class="ref-journal">Curr Opin Neurol. </span>2014;<span class="ref-vol">27</span>:599–606.</span> [<a href="/pubmed/25121518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25121518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.udd.2012.891">Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. <span><span class="ref-journal">Lancet Neurol. </span>2012;<span class="ref-vol">11</span>:891–905.</span> [<a href="/pubmed/22995693" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22995693</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.udd.2006.403">Udd B, Meola G, Krahe R, Thornton C, Ranum LP, Bassez G, Kress W, Schoser B, Moxley R. 140th ENMC International Workshop: Myotonic dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. <span><span class="ref-journal">Neuromuscul Disord. </span>2006;<span class="ref-vol">16</span>:403–13.</span> [<a href="/pubmed/16684600" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16684600</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.umemoto.2009.210">Umemoto G, Nakamura H, Oya Y, Kikuta T. Masticatory dysfunction in patients with myotonic dystrophy (type 1): a 5-year follow-up. <span><span class="ref-journal">Spec Care Dentist. </span>2009;<span class="ref-vol">29</span>:210–4.</span> [<a href="/pubmed/19740152" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19740152</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.van_der_kooi.2005.cd003907">van der Kooi EL, Lindeman E, Riphagen I. Strength training and aerobic exercise training for muscle disease. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2005:CD003907.</span> [<a href="/pubmed/15674918" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15674918</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.verpoest.2008.1654">Verpoest W, De Rademaeker M, Sermon K, De Rycke M, Seneca S, Papanikolaou E, Spits C, Van Landuyt L, Van der Elst J, Haentjens P, Devroey P, Liebaers I. Real and expected delivery rates of patients with myotonic dystrophy undergoing intracytoplasmic sperm injection and preimplantation genetic diagnosis. <span><span class="ref-journal">Hum Reprod. </span>2008;<span class="ref-vol">23</span>:1654–60.</span> [<a href="/pubmed/18408243" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18408243</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.verpoest.2010.327">Verpoest W, Seneca S, De Rademaeker M, Sermon K, De Rycke M, De Vos M, Haentjens P, Devroey P, Liebaers I. The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract. <span><span class="ref-journal">J Assist Reprod Genet. </span>2010;<span class="ref-vol">27</span>:327–33.</span> [<a href="/pmc/articles/PMC2914592/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2914592</span></a>] [<a href="/pubmed/20221684" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20221684</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.veyckemans.2013.794">Veyckemans F, Scholtes JL. Myotonic dystrophies type 1 and 2: anesthetic care. <span><span class="ref-journal">Paediatr Anaesth. </span>2013;<span class="ref-vol">23</span>:794–803.</span> [<a href="/pubmed/23384336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23384336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.wahbi.2017.751">Wahbi K, Babuty D, Probst V, Wissocque L, Labombarda F, Porcher R, B&#x000e9;cane HM, Lazarus A, B&#x000e9;hin A, Lafor&#x000ea;t P, Stojkovic T, Clementy N, Dussauge AP, Gourraud JB, Pereon Y, Lacour A, Chapon F, Milliez P, Klug D, Eymard B, Duboc D. Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1. <span><span class="ref-journal">Eur Heart J. </span>2017;<span class="ref-vol">38</span>:751–8.</span> [<a href="/pubmed/27941019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27941019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.wahbi.2012.1292">Wahbi K, Meune C, Porcher R, B&#x000e9;cane HM, Lazarus A, Lafor&#x000ea;t P, Stojkovic T, B&#x000e9;hin A, Radvanyi-Hoffmann H, Eymard B, Duboc D. Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease. <span><span class="ref-journal">JAMA. </span>2012;<span class="ref-vol">307</span>:1292–301.</span> [<a href="/pubmed/22453570" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22453570</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.wahbi.2018.573">Wahbi K, Porcher R, Lafor&#x000ea;t P, Fayssoil A, B&#x000e9;cane HM, Lazarus A, Sochala M, Stojkovic T, B&#x000e9;hin A, Leonard-Louis S, Arnaud P, Furling D, Probst V, Babuty D, Pellieux S, Clementy N, Bassez G, P&#x000e9;r&#x000e9;on Y, Eymard B, Duboc D. Development and validation of a new scoring system to predict survival in patients with myotonic dystrophy type 1. <span><span class="ref-journal">JAMA Neurol. </span>2018;<span class="ref-vol">75</span>:573–81.</span> [<a href="/pmc/articles/PMC5885178/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5885178</span></a>] [<a href="/pubmed/29404559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29404559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.wang.2018.1174">Wang Y, Pfeiffer RM, Alsaggaf R, Meeraus W, Gage JC, Anderson LA, Bremer RC, Nikolenko N, Lochmuller H, Greene MH, Gadalla SM. Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink. <span><span class="ref-journal">Int J Cancer. </span>2018;<span class="ref-vol">142</span>:1174–81.</span> [<a href="/pmc/articles/PMC5773358/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5773358</span></a>] [<a href="/pubmed/29114849" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29114849</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.wenninger.2018.303">Wenninger S, Montagnese F, Schoser B. Core clinical phenotypes in myotonic dystrophies. <span><span class="ref-journal">Front Neurol. </span>2018;<span class="ref-vol">9</span>:303.</span> [<a href="/pmc/articles/PMC5941986/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5941986</span></a>] [<a href="/pubmed/29770119" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29770119</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.wheeler.2007.572">Wheeler TM, Thornton CA. Myotonic dystrophy: RNA-mediated muscle disease. <span><span class="ref-journal">Curr Opin Neurol. </span>2007;<span class="ref-vol">20</span>:572–6.</span> [<a href="/pubmed/17885447" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17885447</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.win.2012.130">Win AK, Perattur PG, Pulido JS, Pulido CM, Lindor NM. Increased cancer risks in myotonic dystrophy. <span><span class="ref-journal">Mayo Clin Proc. </span>2012;<span class="ref-vol">87</span>:130–5.</span> [<a href="/pmc/articles/PMC3498332/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3498332</span></a>] [<a href="/pubmed/22237010" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22237010</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.winblad.2005.287">Winblad S, Lindberg C, Hansen S. Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1). <span><span class="ref-journal">Neuromuscul Disord. </span>2005;<span class="ref-vol">15</span>:287–92.</span> [<a href="/pubmed/15792867" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15792867</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.wintzen.2007.26">Wintzen AR, Lammers GJ, van Dijk JG. Does modafinil enhance activity of patients with myotonic dystrophy? A double-blind placebo-controlled crossover study. <span><span class="ref-journal">J Neurol. </span>2007;<span class="ref-vol">254</span>:26–8.</span> [<a href="/pmc/articles/PMC1915648/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1915648</span></a>] [<a href="/pubmed/17285226" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17285226</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.yoshida.2018.914">Yoshida K, Aburakawa Y, Suzuki Y, Kuroda K, Kimura T. The frequency and risk factors for ischemic stroke in myotonic dystrophy type 1 patients. <span><span class="ref-journal">J Stroke Cerebrovasc Dis. </span>2018;<span class="ref-vol">27</span>:914–18.</span> [<a href="/pubmed/29306591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29306591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.yotova.2005.177">Yotova V, Labuda D, Zietkiewicz E, Gehl D, Lovell A, Lefebvre JF, Bourgeois S, Lemieux-Blanchard E, Labuda M, Vezina H, Houde L, Tremblay M, Toupance B, Heyer E, Hudson TJ, Laberge C. Anatomy of a founder effect: myotonic dystrophy in Northeastern Quebec. <span><span class="ref-journal">Hum Genet. </span>2005;<span class="ref-vol">117</span>:177–87.</span> [<a href="/pubmed/15883838" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15883838</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.zaki.2007.284">Zaki M, Boyd PA, Impey L, Roberts A, Chamberlain P. Congenital myotonic dystrophy: prenatal ultrasound findings and pregnancy outcome. <span><span class="ref-journal">Ultrasound Obstet Gynecol. </span>2007;<span class="ref-vol">29</span>:284–8.</span> [<a href="/pubmed/17238150" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17238150</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.zampetti.2015.85">Zampetti A, Silvestri G, Manco S, Khamis K, Masciullo M, Bianchi ML, Damiani A, Santoro M, Linder D, Bewley A, Feliciani C. Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study. <span><span class="ref-journal">J Am Acad Dermatol. </span>2015;<span class="ref-vol">72</span>:85–91.</span> [<a href="/pubmed/25440959" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25440959</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myotonic-d.REF.zeesman.2002.222">Zeesman S, Carson N, Whelan DT. Paternal transmission of the congenital form of myotonic dystrophy type 1: a new case and review of the literature. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">107</span>:222–6.</span> [<a href="/pubmed/11807903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11807903</span></a>]</div></li></ul></div></div><div id="myotonic-d.Chapter_Notes"><h2 id="_myotonic-d_Chapter_Notes_">Chapter Notes</h2><div id="myotonic-d.Acknowledgments"><h3>Acknowledgments</h3><p>NIH CAP Award (3 MO1 RR00425-2856)</p></div><div id="myotonic-d.Author_History"><h3>Author History</h3><p>Cameron Adams, MD; Cedars-Sinai Medical Center (1999-2004)<br />Thomas D Bird, MD (2004-present)</p></div><div id="myotonic-d.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>3 October 2019 (tb) Revision: additions to <a href="#myotonic-d.GenotypePhenotype_Correlation">Genotype-Phenotype Correlations</a> and <a href="#myotonic-d.Management">Management</a>; references added: Cumming et al 2019, Johnson et al 2019</div></li><li class="half_rhythm"><div>6 December 2018 (ma) Revision: updated practice guidelines</div></li><li class="half_rhythm"><div>12 July 2018 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 October 2015 (tb) Revision: clarification in Genetic Counseling, Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></div></li><li class="half_rhythm"><div>10 September 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>16 May 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 February 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 November 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 November 2005 (tb) Revision: reference added to Molecular Genetic Testing</div></li><li class="half_rhythm"><div>9 August 2004 (tb) Revision</div></li><li class="half_rhythm"><div>14 August 2001 (tb) Revision by Associate Editor TD Bird, MD</div></li><li class="half_rhythm"><div>17 September 1999 (me) Review posted live</div></li><li class="half_rhythm"><div>31 December 1998 (ca) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1165</span><span class="label">PMID: <a href="/pubmed/20301344" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301344</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/myotonia-c/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/myotonic-d2/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1165&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1165/?report=reader">PubReader</a></li><li><a href="/books/NBK1165/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1165" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1165" style="display:none" title="Cite this Page"><div class="bk_tt">Bird TD. Myotonic Dystrophy Type 1. 1999 Sep 17 [Updated 2019 Oct 3]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1165/pdf/Bookshelf_NBK1165.pdf">PDF version of this page</a> (320K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#myotonic-d.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#myotonic-d.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#myotonic-d.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#myotonic-d.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#myotonic-d.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#myotonic-d.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#myotonic-d.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#myotonic-d.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#myotonic-d.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#myotonic-d.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#myotonic-d.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1760[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DMPK</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1165+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1468800" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1468800" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1468800" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1468800" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301639" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Myotonic Dystrophy Type 2</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Myotonic Dystrophy Type 2<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dalton JC, Ranum LPW, Day JW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301609" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Emery-Dreifuss Muscular Dystrophy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Emery-Dreifuss Muscular Dystrophy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bonne G, Leturcq F, Ben Yaou R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301305" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculopharyngeal Muscular Dystrophy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculopharyngeal Muscular Dystrophy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Trollet C, Gidaro T, Klein P, Périé S, Butler-Browne G, Lacau St Guily J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22643181" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.</a><span class="source">[Eur J Hum Genet. 2012]</span><div class="brieflinkpop offscreen_noflow">Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kamsteeg EJ, Kress W, Catalli C, Hertz JM, Witsch-Baumgartner M, Buckley MF, van Engelen BG, Schwartz M, Scheffer H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Hum Genet. 2012 Dec; 20(12):1203-8. Epub 2012 May 30.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301565" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Central Core Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Central Core Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Malicdan MCV, Nishino I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301344" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301344" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0428f4dd21425a2597b867">Myotonic Dystrophy Type 1 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Myotonic Dystrophy Type 1 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:28:53-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A244DE04149E10000000008EB0365&amp;ncbi_session=CE8A244DE0428F41_2283SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1165%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1165&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1165/&amp;ncbi_pagename=Myotonic Dystrophy Type 1 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A244DE0428F41_2283SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>